2053 Woodbridge Ave. Edison, NJ 08817

Ken is a NJ trial attorney who has published 130 articles in national and New Jersey publications on litigation topics. He has been selected to write the new ABA book: DUI and Drug Possession Defense".

Sunday, April 15, 2018

Consent to a search must be knowingly and voluntarily 68 N.J. 349 (1975) State v. Johnson

Consent to a search must be knowingly and voluntarily 68 N.J. 349 (1975)
State v. Johnson
The Supreme Court of New Jersey.
Argued May 13, 1975.
Decided October 8, 1975.
The opinion of the Court was delivered by SULLIVAN, J.
This is a search and seizure case wherein defendant, who has been indicted for possession of narcotics and possession with intent to distribute, moved to suppress evidence found by the police during the search of an apartment where defendant kept some personal belongings. The State sought to justify the search on the basis of consent.[1] The trial judge granted the motion. The Appellate Division reversed and remanded the matter for redetermination on the record already made on the ground that the trial judge had applied improper standards in passing upon the consent issue. By leave granted defendant appeals. R. 2:2-2(b). We modify the Appellate Division ruling to the extent hereinafter indicated.
*352 At the hearing on the motion to suppress, the State and defendant presented conflicting factual versions as to the circumstances leading up to the search and whether or not consent had been given. Defense counsel argued that the State had not proved "a voluntary type of waiver of one's Fourth Amendment right." The trial judge in ruling on the motion made no specific finding as to which version he found to be credible. He said he had weighed the testimony of all of the witnesses and was unable to conclude that the State had proved by clear and positive evidence that the consent was knowingly, intelligently, voluntarily and unequivocally given to search the apartment. He added that the knowledge aspect "goes to the knowledge of whether or not she had a right to refuse to have the apartment searched at all or knowledge of whether or not they are waiving their constitutional right against invasion of privacy."
In Schneckloth v. Bustamonte, 412 U.S. 218, 93 S. Ct. 2041, 36 L. Ed. 2d 854 (1973) the United States Supreme Court held that where the subject of a search is not in custody and the state attempts to justify the search on the basis of consent, the Fourth and Fourteenth Amendments require that it demonstrate that the consent was in fact voluntarily given, and not the result of duress or coercion, express or implied, and that while knowledge of a right to refuse consent is one factor to be taken into account, it is not an indispensable element of an effective consent. 412 U.S. 248-249, 93 S. Ct. 2041.
Schneckloth rejected the contention that the validity of a consent to a search in a non-custodial situation should be measured in terms of waiver, and that the state should be required to show that there had been an intentional relinquishment of a known constitutional right. Instead, the court held that the test to be applied was one of voluntariness to be determined from the totality of the circumstances. Id. at 235-247, 93 S. Ct. 2041.
Based on Schneckloth the Appellate Division held that the yardstick used by the trial judge no longer represented *353 the measure to be applied in determining whether there had been a violation of Fourth Amendment rights and remanded the matter to the trial judge for redetermination of the motion to suppress on the record already made, using the standards set forth in Schneckloth.
Schneckloth is controlling on state courts insofar as construction and application of the Fourth Amendment is concerned and is dispositive of defendant's federal constitutional argument. However, each state has the power to impose higher standards on searches and seizures under state law than is required by the Federal Constitution. Cooper v. California, 386 U.S. 58, 62, 87 S. Ct. 788, 17 L. Ed. 2d 730 (1967).
The New Jersey Constitution of 1947, Art. I, par. 7, provides that "[T]he right of the people to be secure in their persons, houses, papers and effects, against unreasonable searches and seizures shall not be violated * * *." While counsel for defendant did not contend, either on argument of the motion or on appeal, that our State constitutional provision against unreasonable searches should be interpreted to give the individual greater protection than is provided by the Fourth Amendment, this Court, sua sponte, posed the issue and afforded counsel the opportunity to submit supplemental memoranda on the question. The Court has the benefit of the additional arguments presented.[2]
We conclude that under Art. I, par. 7 of our State Constitution the validity of a consent to a search, even in a non-custodial situation, must be measured in terms of waiver; i.e., where the State seeks to justify a search on the *354 basis of consent it has the burden of showing that the consent was voluntary, an essential element of which is knowledge of the right to refuse consent.
Many persons, perhaps most, would view the request of a police officer to make a search as having the force of law. Unless it is shown by the State that the person involved knew that he had the right to refuse to accede to such a request, his assenting to the search is not meaningful. One cannot be held to have waived a right if he was unaware of its existence.
However, in a non-custodial situation, such as is here presented, the police would not necessarily be required to advise the person of his right to refuse to consent to the search. Our decision is only that in such a situation if the State seeks to rely on consent as the basis for a search, it has the burden of demonstrating knowledge on the part of the person involved that he had a choice in the matter.[3]
We agree that the motion should be remanded to the trial judge for redetermination on the record already made and such additional proofs as the parties may offer, but applying the standards heretofore set forth insofar as defendant's right under our State constitution to be secure against unreasonable searches is involved. On the remand, the trial judge should make specific findings as to the facts disputed at the hearing and as to knowledge by the occupant of her right to refuse consent so that a reviewing court may know precisely the basis of the ruling.
Except for the instant case, this decision is to have prospective effect, applying only to searches based on consent which take place after the date of this opinion.
SCHREIBER, J. (concurring).
Obviously, as both the majority and dissenting opinions observe, because of the *355 United States Supreme Court opinion in Schneckloth v. Bustamonte, 412 U.S. 218, 93 S. Ct. 2041, 36 L. Ed. 2d 854 (1973), knowledge of a right to refuse consent to a search is not a prerequisite of an effective consent to validate a search under the Fourth and Fourteenth Amendments of the United States Constitution. The remaining issue is whether there has been a violation of Article I, ¶ 7 of the New Jersey Constitution which provides that "[t]he right of the people to be secure in their persons, houses, papers, and effects against unreasonable searches and seizures, shall not be violated; * * *." In other words, was the search unreasonable under all the circumstances? Cf. State v. Davis, 50 N.J. 16, 22 (1967); United States v. Rabinowitz, 339 U.S. 56, 70 S. Ct. 430, 94 L. Ed. 653 (1950); and Cady v. Dombrowski, 413 U.S. 433, 439, 93 S. Ct. 2523, 37 L. Ed. 2d 706 (1973) where the Court noted: "The ultimate standard set forth in the Fourth Amendment is reasonableness."
A search conducted after a voluntary consent is clearly reasonable. State v. King, 44 N.J. 346 (1965). Consent contemplates the exercise of a choice, and choice entails the opportunity to evaluate the available options. The right of self-decision is effectively safeguarded if the occupant of the premises knows that the search may be refused. This knowledge may be imputed from information furnished by the police. In the absence of that knowledge a search is unreasonable.
I would not, as the majority does, rationalize the problem in terms of waiver. Justice Black in Green v. United States, 355 U.S. 184, 191, 78 S. Ct. 221, 2 L. Ed. 2d 199 (1957) wrote: "`Waiver' is a vague term used for a great variety of purposes, good and bad, in the law." The dissent, for example, utilizes one definition of the term, an intentional relinquishment or abandonment of a known right or privilege. See dissenting opinion, p. 361. In this context, one could logically contend that warnings should include the consequences of permitting the search as well as the right to have present an attorney. Wilberding, "Miranda-Type *356 Warnings for Consent Searches," 47 North Dak. L. Rev. 281, 284 (1971).
It is significant to note that none of the dissenting Justices in Schneckloth v. Bustamonte, supra, urged that Miranda-type warnings be required. The reasonableness of this position becomes apparent when recognition is given to the fact that the warnings in Miranda v. Arizona, 384 U.S. 436, 477, 86 S. Ct. 1602, 16 L. Ed. 2d 694 (1966) apply only to custodial interrogations. It would be anomalous indeed to require Miranda-type warnings with respect to consent searches and not for Fifth Amendment non-custodial questioning. Such an approach would tend to cripple effective law enforcement and ignore the balancing concept inherent in determining what is "unreasonable."
I concur in the remand for the purposes enunciated by the majority.
PASHMAN, J. (dissenting).
This case concerns the validity of a consent search conducted without a warrant by three members of the Newark Police Department's Narcotics Squad. After hearing sharply disputed testimony on the question of consent, the trial court granted defendant's motion to suppress. As the majority properly notes, the trial judge made no specific finding as to which factual version was credible, stating instead that he was unable to conclude that "the State has sustained the necessary burden by proving by clear and positive evidence that the consent was knowingly, intelligently, voluntarily and unequivocally given" to search the premises. The Appellate Division reversed and remanded, holding that the trial court had applied an improper standard in resolving the consent issue, "[t]he criterion is simply whether `the consent was in fact voluntarily given and not the result of duress or coercion, express or implied.'" (quoting from Schneckloth v. Bustamonte, 412 U.S. 218, 248, 93 S. Ct. 2041, 36 L. Ed. 2d 854 (1973)). Today this Court in remanding the case for further findings by the trial court concludes that the Schneckloth *357 standard for resolving the consent issue is controlling as to the construction of the federal constitution but that this case is to be decided on the basis of a proper construction of the search and seizure provisions of the New Jersey Constitution. Ante at 352-353. While I agree with the conclusion of the majority that this case must be remanded for more explicit factual findings, I cannot subscribe to the reasoning of the Court insofar as it concerns the standard for determining the issue of consent to conduct a warrantless search under the New Jersey Constitution. Accordingly, I must dissent.
The Essex County Grand Jury charged defendant in a two-count indictment with possession of narcotics in violation of N.J.S.A. 24:21-20 (Supp. 1975-76), and possession of narcotics with intent to distribute in violation of N.J.S.A. 24-21-19 (a) (1) (Supp. 1975-76). The indictment resulted from a search of the apartment occupied by defendant's finance on the night of December 6, 1973. According to her testimony, she was in bed in her Newark apartment when the detectives knocked on her door seeking access to conduct a search. Although the witness testified that she did not at any time give the officers permission to enter her apartment, one of the detectives testified that when the officers stated the purpose of their visit she invited them in to satisfy their curiosity. According to the officers, they first explained to the witness that they suspected that defendant was dealing in narcotics from the apartment and then administered the warnings required by Miranda v. Arizona, 384 U.S. 436, 86 S. Ct. 1602, 16 L. Ed. 2d 694 (1966). After the witness stated that she understood her rights, the officers testified that she denied any knowledge of narcotics in her apartment and then led them into her apartment where an orderly search was conducted. The officers added that the witness also directed them to a dresser drawer in which defendant kept his personal items where, among other items, a plastic bag containing a white powder was discovered. After the *358 officers repeated the Miranda warnings, the witness identified the items as belonging to defendant.
In addition to denying that she had given the officers permission to enter her apartment, the witness stated that the detectives did not explain the purpose of their visit prior to gaining entry but merely asked her if there were any narcotics on the premises. The witness also stated that she was only given the Miranda warnings once and that was after the officers had entered her apartment and had begun searching. Finally, the witness stated that no one asked her where defendant kept his personal belongings and that she did not observe anything taken from the dresser drawer. Defendant was arrested when he subsequently returned to the apartment.
Prior to the United States Supreme Court's resolution of the consent issue in Schneckloth, supra, this Court in State v. King, 44 N.J. 346 (1965) emphasized that when an individual consents to a search of his premises he relinquishes important constitutional safeguards. Defendant in King had been convicted of armed robbery and had moved unsuccessfully prior to trial to suppress a gun, cap and coat which had been found in a search of an apartment shared by defendant and another. The trial court denied defendant's motion to suppress, finding that defendant and the lessee of the apartment had consented to the search. 44 N.J. at 351. Although we concluded that sufficient evidence was before the trial court to warrant that finding, we made it clear that the implications of such a conclusion require that a heavy burden be placed on the State in showing consent:
The primary question on this appeal is whether the defendant voluntarily gave his consent to the search of the apartment. The general principles of law which govern this issue are well settled. When an accused consents to a search of his premises, he relinquishes the Fourth Amendment protection which prohibits unreasonable searches and seizures. Implicit in the very nature of the term "consent" is the requirement of voluntariness. To be voluntary the consent must be "unequivocal and specific" and "freely and intelligently given." The burden of proof is on the State to establish by clear and positive testimony that the consent was so given. [44 N.J. at 352 (citations omitted)] *359 See also State v. Rice, 115 N.J. Super. 128, 131 (App. Div. 1971); State v. Guadiosi, 97 N.J. Super. 565, 571-72 (App. Div. 1967); State v. Price, 108 N.J. Super. 272, 282 (Law Div. 1970).
The Appellate Division has concluded that the standards governing consent searches set forth in King and the cases which have relied upon it have been substantially eclipsed by the Supreme Court's decision in Schneckloth v. Bustomonte, supra. I cannot agree. The majority of this Court while rejecting the Schneckloth view that knowledge by the person to be searched of his right to refuse is not a prerequisite for a valid consent search, adopts a standard for determining validity which in my view falls short of what is necessary to protect the privacy rights of the consenting individual. Accordingly, I cannot join the majority opinion and my reasons follow.
Defendant in Schneckloth was convicted in a California court after stolen checks were discovered in a car in which he was a passenger. The search was conducted pursuant to the consent of one of the occupants after the car was stopped for displaying inoperative lights. Defendant's conviction was affirmed on appeal, People v. Bustamonte, 270 Cal. App. 2d 648, 76 Cal. Rptr. 17 (Ct. App. 1969). Thereafter defendant sought a writ of habeas corpus in the federal district court. It was denied, but on appeal the Ninth Circuit vacated the order denying the writ, reasoning that since consent is a waiver of constitutional rights, the State must show not only the absence of coercion, but also that the individual knew that consent could have been withheld. Bustamonte v. Schneckloth, 448 F.2d 699 (9 Cir.1971). See also Schoepflin v. United States, 391 F.2d 390 (9 Cir.1968), cert. den. 393 U.S. 865, 89 S. Ct. 146, 21 L. Ed. 2d 133 (1968); Cipres v. United States, 343 F.2d 95 (9 Cir.1965).
On appeal the United States Supreme Court reversed the Court of Appeals by adopting a "totality of the circumstances" test to govern the validity of consent searches authorized by subjects not in custody:
*360 Our decision today is a narrow one. We hold only that when the subject of a search is not in custody and the State attempts to justify a search on the basis of his consent, the Fourth and Fourteenth Amendments require that it demonstrate that the consent was in fact voluntarily given, and not the result of duress or coercion, express or implied. Voluntariness is a question of fact to be determined from all the circumstances, and while the subject's knowledge of a right to refuse is a factor to be taken into account, the prosecution is not required to demonstrate such knowledge as a prerequisite to establishing a voluntary consent.[1] [412 U.S. at 248-49, 93 S. Ct. at 2059 (footnote omitted)]
In concluding that consent to conduct a search must be determined by a voluntariness standard which in turn requires an evaluation of all the attendant circumstances, the Court resorted to the analysis employed in a line of cases which explored the voluntariness of a defendant's confession gauged against the requirements of the fourteenth amendment, e.g., Davis v. North Carolina, 384 U.S. 737, 86 S. Ct. 1761, 16 L. Ed. 2d 895 (1966); Reck v. Pate, 367 U.S. 433, 81 S. Ct. 1541, 6 L. Ed. 2d 948 (1961); Payne v. Arkansas, 356 U.S. 560, 78 S. Ct. 844, 2 L. Ed. 2d 975 (1958); Fikes v. Alabama, 352 U.S. 191, 77 S. Ct. 281, 1 L. Ed. 2d 246 (1957); Haley v. Ohio, 332 U.S. 596, 68 S. Ct. 302, 92 L. Ed. 224 (1948); Ashcraft v. Tennessee, 322 U.S. 143, 64 S. Ct. 921, 88 L. Ed. 1192 (1944); Chambers v. Florida, 309 U.S. 227, 60 S. Ct. 472, 84 L. Ed. 716 (1940). 412 U.S. at 223-26, 93 S. Ct. 2041, 36 L. Ed. 2d 854. After observing that none of the cases turned on the presence or absence of a single factor and that in none had the Court construed the fourteenth amendment to require a showing that defendant knew he had a right to refuse to *361 answer questions, 412 U.S. at 226-27, 93 S. Ct. 2041, the Court concluded that in the context of a consent search:
While knowledge of the right to refuse consent is one factor to be taken into account, the government need not establish such knowledge as the sine qua non of an effective consent.[2] [412 U.S. at 227, 93 S. Ct. at 2048]
In deciding Schneckloth, the majority rejected a waiver analysis of the consent issue, i.e., that by consenting to a search an individual waives his rights under the fourth and fourteenth amendments, a waiver which may be established only by a showing by the state of "an intentional relinquishment or abandonment of a known right or privilege." Johnson v. Zerbst, 304 U.S. 458, 464, 58 S. Ct. 1019, 1023, 82 L. Ed. 1461 (1938). Observing that Johnson involved an alleged waiver of the right to counsel in a federal criminal trial, the Court emphasized that "[a]lmost without exception" the Johnson standard has only been applied to those rights which guarantee a criminal defendant a fair trial. 412 U.S. at 237, 93 S. Ct. 2041. The Court, however, declined to extend the knowing and intelligent waiver standard to the search and seizure situation:
There is a vast difference between those rights that protect a fair criminal trial and the rights guaranteed under the Fourth Amendment. Nothing, either in the purposes behind requiring a "knowing" and "intelligent" waiver of trial rights, or in the practical application of such a requirement suggests that it ought to be extended to the constitutional guarantee against unreasonable searches and seizures.[3] [412 U.S. at 241, 93 S. Ct. at 2055]
*362 Three members of the Court were not persuaded by the reasoning of the majority, and in separate dissenting opinions underscored the defects in the analysis and result reached by the Court. Emphasizing that the search could only be justified on the basis of consent, Justice Brennan was unable to to comprehend how a citizen can waive a right which he is unaware exists:
The Court holds today that an individual can effectively waive his right even though he is totally ignorant of the fact that, in the absence of his consent, such invasions of his privacy would be constitutionally prohibited. It wholly escapes me how our citizens can meaningfully be said to have waived something as precious as a constitutional guarantee without ever being aware of its existence. In my view, the Court's conclusion is supported neither by "linguistics," nor by "epistemology," nor, indeed, by "common sense." I respectfully dissent. [412 U.S. at 277, 93 S. Ct. at 2073 (Brennan, J. dissenting)]
Justice Marshall found the opinion of the Court "misleading" in several respects: (1) the standard selected by the Court was derived from a justification of consent searches which is inconsistent with the Court's treatment of other exceptions to the fourth amendment; (2) the voluntariness standard was developed in a very different context implicating different policies; and (3) the majority mischaracterized the Court's prior cases dealing with consent searches. 412 U.S. at 280, 93 S. Ct. 2041 (Marshall, J. dissenting). Characterizing his approach to the problem as "straightforward and * * * obvious," Justice Marshall had difficulty accepting the proposition that a decision made without knowledge of all the alternatives could be characterized as a choice at all. 412 U.S. at 284, 93 S. Ct. 2041 (Marshall, J. *363 dissenting). Consequently, Justice Marshall would hold that at a minimum the prosecution may not rely on consent to justify a search unless the subject knew that he could refuse. Proceeding from this premise, Justice Marshall concluded that a fair allocation of the burden of proof would place the onus of showing such knowledge on the prosecution. Observing that there are several ways for the state to discharge that burden, Justice Marshall pointed out that one way of proving knowledge would be evidence that prior to conducting the search, the police notified the subject that he had a right to refuse:
The burden on the prosecutor would disappear, of course, if the police, at the time they requested consent to search, also told the subject that he had a right to refuse consent and that this decision to refuse would be respected. The Court's assertions to the contrary notwithstanding, there is nothing impractical about this method of satisfying the prosecution's burden of proof.[4] [412 U.S. at 286, 93 S. Ct. at 2078 (Marshall, J. dissenting (footnote omitted)]
In response to the majority's references to practicality, Justice Marshall expressed the fear that what in reality *364 motivated the Court was the continued ability of the authorities to take advantage of an individual's ignorance of his rights thereby accomplishing by "subterfuge" what could not be achieved by relying only on the "knowing relinquishment of constitutional rights." 412 U.S. at 288, 93 S. Ct. 2041 (Marshall, J. dissenting). In his view, the ultimate effect of the Court's decision was a realignment of the balance struck by the framers between the interests of the police and basic rights as a result of the majority's own convictions about the needs of law enforcement:
In the final analysis, the Court now sanctions a game of blindman's buff, in which the police always have the upper hand, for the sake of nothing more than the convenience of the police. But the guarantees of the Fourth Amendment were never intended to shrink before such an ephemeral and changeable interest. The Framers of the Fourth Amendment struck the balance against this sort of convenience and in favor of certain basic civil rights. It is not for this Court to restrike that balance because of its own views of the needs of law enforcement officers. I fear that that is the effect of the Court's decision today. [412 U.S. at 289-90, 93 S. Ct. at 2079 (Marshall, J. dissenting)]
Despite the substantial shortcomings of the standard selected by the Schneckloth majority,[5] insofar as it represents *365 the Supreme Court's construction of the federal constitution, we are bound by it. As the majority in the present case correctly notes, Ante at 353 the Supreme Court recently spoke to this issue in Oregon v. Hass, 420 U.S. 714, 718, 95 S. Ct. 1215, 1219, 43 L. Ed. 2d 570, 576 (1975).
[O]f course, a State may not impose such greater restrictions as a matter of federal constitutional law when this Court specifically refrains from imposing them.[6] [emphasis in original; footnote omitted]
I have previously recognized this limitation in my separate opinion in State v. Miller, 67 N.J. 229, 241 (1975) (Pashman, J. dissenting).
Recognition of this principle, however, does not dictate an uncritical acceptance of the standards selected by the Supreme Court under the fourth amendment governing the validity of consent searches. We remain free to apply criteria which afford the individual greater safeguards against official intrusion as a matter of state law. Indeed, this concept has been emphasized specifically in the search and seizure context:
Our holding, of course, does not affect the State's power to impose higher standards on searches and seizures than required by the Federal Constitution if it chooses to do so. [Cooper v. California, 386 U.S. 58, 62, 87 S. Ct. 788, 791, 17 L. Ed. 2d 730 (1967)]
See also Oregon v. Hass, supra 420 U.S. at 719, 95 S. Ct. at 1219, 43 L. Ed. 2d at 576 n. 4; Sibron v. New York, 392 U.S. 40, 60-61, 88 S. Ct. 1889, 20 L. Ed. 2d 917 (1968); *366 State v. Miller, supra, 67 N.J. at 242 (Pashman, J. dissenting).
Since our Constitution expressly protects the citizens of this State from unreasonable searches and seizures,[7] I would construe N.J. Const. (1947), Art. I, ¶ 7 to require the State to affirmatively demonstrate that the subject of a consent search knew that he had a right to withhold his consent and that his decision would be respected by the authorities. This is the plain implication of our decision in State v. King, supra, when we spoke in terms of consent freely and intelligently given. An intelligent choice presupposes an awareness of all the available alternatives.
I also believe that the arrival of officers at the door of one's residence, particularly at night, for the purpose of conducting a search has an inherently coercive effect upon the occupant. Cf. Bumper v. North Carolina, 391 U.S. 543, 548-49, 88 S. Ct. 1788, 20 L. Ed. 2d 797 (1968). Accordingly, I would hold that the police must discharge their burden of proof on the issue of the subject's knowledge by showing that the one from whom consent was elicited was advised that he had a right to refuse to consent, that his refusal would be respected, and that anything uncovered by the search could be used in evidence against him. In this respect, I agree with the observations of Justice Marshall in his dissent in Schneckloth, supra, that such a warning would not unduly disrupt police procedures by destroying the informality of the exchange. See note 4, supra. In any event, the warning would only advise the subject of facts which he is clearly entitled to know.
*367 I also appreciate the fact that many of the courts which have considered the problem have rejected the warning approach. See Schneckloth, supra, 412 U.S. at 231 nn. 13, 14, 93 S. Ct. 2041, 36 L. Ed. 2d 854, see also State v. McKnight, 52 N.J. 35, 53 n. 4 (1968). Prior to Schneckloth, however, this view was by no means universally accepted. See Perkins v. Henderson, 418 F.2d 441, 442 (5 Cir.1969); United States v. Nikrasch, 367 F.2d 740, 744 (7 Cir.1966); United States v. Moderacki, 280 F. Supp. 633, 636 (D. Del. 1968); United States v. Blalock, 255 F. Supp. 268, 269-70 (E.D. Pa. 1966). See also United States v. Fisher, 329 F. Supp. 630, 634-35 (D. Minn. 1971); Wefing & Miles, "Consent Searches and the Fourth Amendment: Voluntariness and Third Party Problems," 5 Seton Hall L. Rev. 211, 251-52 (1974); Note, 67 Colum. L. Rev. 130, 146-48 (1967). Indeed, the American Law Institute has recommended the administration of such warnings in its Model Code of Pre-arraignment Procedures:
(2) Required Warning to Persons Not in Custody or Under Arrest. Before undertaking a search under the provisions of this Article an officer present shall inform the individual whose consent is sought that he is under no obligation to give such consent and that anything found may be taken and used in evidence.
(3) Required Warning to Persons in Custody or Under Arrest. If the individual whose consent is sought under Subsection (1) is in custody or under arrest at the time such consent is offered or invited, such consent shall not justify a search and seizure under Section SS 240.1 unless in addition to the warning required by Subsection (2), such individual has been informed that he has the right to consult an attorney, either retained or appointed, and to communicate with relatives or friends, before deciding whether to grant or withhold consent. [Model Code of Pre-arraignment Procedure, § SS 240.2(2), (3) (Proposed Official Draft 1975)]
I find it inconceivable and incomprehensible to suppose that an individual can be said to have relinquished privileges as fundamental as those embodied in our constitutional guarantees against unreasonable searches and seizures unless it clearly and unmistakably appears that the subject of the *368 search knew that he did not have to submit to the official request. Schneckloth, supra, cannot withstand close scrutiny when it treats that knowledge as merely one factor to be considered in determining the validity of a consent search. The majority's formulation falls short of requiring an express warning to the individual as to his rights. In my judgment, such approaches merely pay lip service to the subject's awareness of his rights in an effort to accommodate the convenience of law enforcement at the expense of important personal freedoms. I am distressed that the approach of the majority does not adequately protect these freedoms. I must respectfully dissent.
SCHREIBER, J., concurring in result.
For modification and remandment Chief Justice HUGHES, Justices MOUNTAIN, SULLIVAN, CLIFFORD, and SCHREIBER and Judge CONFORD 6.
Dissenting Justice PASHMAN 1.
NOTES
[1] According to the police witnesses, the consent was given by a woman who was defendant's fiancée and who occupied the apartment. Defendant's standing to challenge the search seems clear.
[2] It is recognized that Art. I, par. 7, is taken almost verbatim from the Fourth Amendment and until now has not been held to impose higher or different standards than those called for by the Fourth Amendment. However, we have the right to construe our State constitutional provision in accordance with what we conceive to be its plain meaning. R. 3:5-7, which establishes a procedure for the suppression of illegally seized evidence, applies to any search and seizure found to be unlawful, whether under federal or state law.
[3] Several ways by which the State could satisfy this burden are detailed by Justice Marshall in his dissenting opinion in Schneckloth, supra, 412 U.S. at 286, 93 S. Ct. 2041.
[1] The Court was careful to note that its decision only applied to subjects who purportedly consented to a search in non-custodial situations. See 412 U.S. at 240 n. 29, 93 S. Ct. at 2055; 412 U.S. at 247 n. 36, 93 S. Ct. at 2058. For a collection of the pre-Schneckloth cases dealing with consent searches in the custodial context, see Annotation, "Validity of consent to search given by one in custody of officers," 9 A.L.R.3d 858 (1966).
[2] The Court also found nothing in its previous decisions suggesting the requirement of proof that defendant knew he had a right to refuse to consent to a search. 412 U.S. at 234, 93 S. Ct. 2041. See Bumper v. North Carolina, 391 U.S. 543, 88 S. Ct. 1788, 20 L. Ed. 2d 797 (1968); Johnson v. United States, 333 U.S. 10, 68 S. Ct. 367, 92 L. Ed. 436 (1948); Davis v. United States, 328 U.S. 582, 66 S. Ct. 1256, 90 L. Ed. 1453 (1946); Amos v. United States, 255 U.S. 313, 41 S. Ct. 266, 65 L. Ed. 654 (1921).
[3] Although the Court's analysis of the consent issue was premised on concepts of voluntariness, the majority specifically rejected an analogy to Miranda v. Arizona, 384 U.S. 436, 86 S. Ct. 1602, 16 L. Ed. 2d 694 (1966), concluding that "[t]he considerations that informed the Court's holding in Miranda are simply inapplicable in the present case." 412 U.S. at 246, 93 S. Ct. at 2058. In the Court's view, consent searches normally occur on the subject's own territory and consequently "the specter of incommunicado police interrogation in some remote station house is simply inapposite." [412 U.S. at 247, 93 S. Ct. at 2058]
[4] Justice Marshall added:
The Court contends that if an officer paused to inform the subject of his rights, the informality of the exchange would be destroyed. I doubt that a simple statement by an officer of an individual's right to refuse consent would do much to alter the informality of the exchange, except to alert the subject to a fact that he surely is entitled to know. It is not without significance that for many years the agents of the Federal Bureau of Investigation have routinely informed subjects of their right to refuse consent, when they request consent to search. Note, Consent Searches: A Reappraisal After Miranda v. Arizona, 67 Col. L. Rev. 130, 143 n. 75 (1967) (citing letter from J. Edgar Hoover). The reported cases in which the police have informed subjects of their right to refuse consent show, also, that the information can be given without disrupting the casual flow of events. See, e.g., United States v. Miller, 395 F.2d 116 (C.A. 7 1968). What evidence there is, then, rather strongly suggests that nothing disastrous would happen if the police, before requesting consent, informed the subject that he had a right to refuse consent and that his refusal would be respected. [412 U.S. at 287-88, 93 S. Ct. at 2078 (Marshall, J. dissenting) (footnote omitted)]
[5] See Wefing & Miles, "Consent Searches and the Fourth Amendment: Voluntariness and Third Party Problems," 5 Seton Hall L. Rev. 211, 212 (1974), where the authors summarize Schneckloth as follows:
Bustamonte is a strained, self-contradictory opinion which not only represents a drastic departure from the Court's own previous cases, but also undermines a substantial body of prior federal case law which reflected a sustained and sometimes creative effort to develop a coherent consent-search doctrine. In effect, this case eliminated the "waiver" requirement, a concept which has emerged as a critical factor in Supreme Court decisions and which has been heavily relied upon by the lower federal courts. Rather, it adopted the "totality of the circumstances" test which was employed primarily by the California state courts and which consisted of a more relaxed voluntariness standard than that employed by the federal courts. Further, the Bustamonte Court equated the "voluntariness" of consent obtained for a search in a non-custodial setting with the "voluntariness" of a confession elicited as the result of police interrogation. In so doing, it applied to the fourth amendment consent issue a line of confession cases involving the problem of voluntariness which had been rendered obsolete by Miranda v. Arizona, and arrived at the conclusion that a person could voluntarily waive fourth amendment rights even without knowledge that they existed. [Footnotes omitted]
[6] See also the Court's commentary on the observations of the Oregon Supreme Court in State v. Florance, Or., 527 P.2d 1202 (1974). 420 U.S. at 719, n. 4, 95 S. Ct. at 1219, 43 L. Ed. 2d at 576.
[7] N.J. Const. (1947), Art. I, ¶ 7 provides as follows:
7. Freedom from unreasonable searches and seizures; warrant
7. The right of the people to be secure in their persons, houses, papers, and effects, against unreasonable searches and seizures, shall not be violated; and no warrant shall issue except upon probable cause, supported by oath or affirmation, and particularly describing the place to be searched and the papers and things to be seized.


Sunday, April 01, 2018

Chain of custody addressed State of New Jersey v. Robert W. Morton (A-18/19-97) 155 N.J. 383.


Chain of custody addressed State of New Jersey v. Robert W. Morton (A-18/19-97) 155 N.J. 383.
VI.  The Surgical Gloves
    Defendant contends that the court committed reversible error by admitting the recovered surgical gloves into evidence. At the guilt phase, defendant made no objection to the admission of the gloves. During the penalty phase, however, defendant objected to their admission as irrelevant. Defendant now argues that the State failed to provide a proper chain of custody for the gloves. He also argues that the tear in one glove's index finger, which was not discovered until after the FBI had performed its tests, established tampering sufficient to preclude the admission of that glove. Governing our review of this claim is the plain error standard, which requires the admission of the gloves "to have been clearly capable of producing an unjust result."  R. 2:10-2. We find no such error.
    Through the testimony of each officer who possessed the gloves, the State established an unbroken chain of custody.  See State v. Brown, 99 N.J. Super. 22, 27 (App. Div.), certif. denied, 51 N.J. 468 (1968). Each glove was placed in a marked envelope and transferred among authorized law enforcement agents. See State v. Johnson, 90 N.J. Super. 105, 114-15 (App. Div. 1965), aff'd, 46 N.J. 289 (1966). Ample evidence supports the trial court's finding that the State proved an unbroken chain of custody.  SeeBrown, supra, 99 N.J. Super. at 27 ("Whether the requisite chain of possession has been sufficiently established to justify admission of the exhibit is a matter committed to the discretion of the trial judge, and his determination will not be overturned in the absence of a clearly mistaken exercise thereof."); see also State v. Farfalla, 113 N.J. Super. 557, 559-60 (App. Div.) (citing Brown with approval for the proposition that admissibility in a case involving a contested chain of custody involves an exercise of the trial court's discretion), certif. denied, 58 N.J. 394 (1971).  "Furthermore, a defect in the chain of custody goes to the weight, not the admissibility, of the evidence introduced."  United States v. Matta-Ballesteros, 71 F.3d 754, 769 (9th Cir. 1995) (discussing admissibility under standard of Federal Rule of Evidence 901), cert. denied, ___ U.S. ___, 117 S. Ct. 965, 136 L. Ed.2d 850 (1997); see also Biunno, Current N.J. Rules of Evidence, 1991 Supreme Court Committee Comment on N.J.R.E. 901 (1995) ("Rule 901 generally follows Fed. R. Evid. 901 . . . .").
    In addition, the fact that the FBI was the first to note the tear in one glove is not a sufficient reason to preclude the gloves' admission into evidence. Everyone who possessed the glove testified that he had not tampered with it. The FBI experts, a DNA analyst and a fingerprint analyst, testified that they did not tear the glove during the testing procedures. Because the custodians were law enforcement officers, moreover, the prosecutor was not obligated "to negate every possibility of substitution or change in condition of the evidence."  State v. Brunson, 132 N.J. 377, 393 (1993). 
    Through cross-examination, defendant raised the possibility that law enforcement agents had torn the gloves. For example, under examination by defense counsel, the FBI fingerprint analyst conceded that experts accidentally have torn evidence during testing in other cases. Such concerns, however, go to the weight, not the admissibility of evidence.  Brown, supra, 99 N.J. Super.at 27-28. Thus, we reject defendant's claim of error.

EXECUTIVE ORDER 6 REPORTNEW JERSEY COMPASSIONATE USE MEDICAL MARIJUANA ACT..


EXECUTIVE ORDER 6 REPORTNEW JERSEY COMPASSIONATE USE MEDICAL MARIJUANA ACT..
Issued by Acting Commissioner Shereef Elnahal, M.D., M.B.A. March 23, 2018
page2image464 page2image1048
TABLE OF CONTENTS
page2image2480 page2image3064
EXECUTIVE SUMMARY ................................................................................................................................................................ 3 Department Action Items ........................................................................................................................................................ 3 Regulatory Action Items .......................................................................................................................................................... 3 Statutory Recommendations................................................................................................................................................... 5 Additional Considerations ....................................................................................................................................................... 7
NEW JERSEY COMPASSIONATE USE MEDICAL MARIJUANA ACT...............................................................................................9 REGULATIONS GOVERNING THE MEDICINAL MARIJUANA PROGRAM ..................................................................................... 9 MEDICINAL MARIJUANA PROGRAM REVIEW .......................................................................................................................... 10
An Evaluation of the Current Rules Regulating the Operations and Siting of Dispensaries and Cultivation Facilities, Particularly Focusing on Whether the Rules Should Be Revised to Remove Obstructions to Expansion ............................. 10
A Review of the Current Process for Obtaining a License to Operate a Medical Marijuana Dispensary, Including Recommendations to Expedite That Process ........................................................................................................................ 11
An Examination of Conditions for Participating Physicians in the Program to Ensure That Any Such Requirements Are Not Needlessly Onerous .............................................................................................................................................................. 12
An Analysis of the Current List of Debilitating Medical Conditions for Which Medical Marijuana May Be Authorized Pursuant to N.J.S.A. 24:6I-3, and a Recommendation as to Whether Doctors Should Be Given Flexibility to Make Their Determinations on their Own................................................................................................................................................ 14
An Assessment of the Methods Through Which Patients or Their Primary Caregivers Are Obtaining Medical Marijuana and a Recommendation of Whether Rules Should be Amended to Approve Additional Methods That Could Facilitate Patient Access........................................................................................................................................................................ 16
A Review of Regulations that Govern the Forms in Which Medical Marijuana Can Be Ingested, Taking into Consideration the Needs for Different Methods for Different Patients ....................................................................................................... 18
Additional Considerations ..................................................................................................................................................... 19 CONCLUSION ............................................................................................................................................................................. 21 ATTACHMENTS .......................................................................................................................................................................... 22
Executive Summary Matrix Executive Order 6
page2image17168
Page 2
page3image648 page3image1232
EXECUTIVE SUMMARY1
Governor Murphy issued Executive Order No. 6 (2018) (EO 6) directing the New Jersey Department of Health2 (Department) to undertake a review of all aspects of New Jersey’s Medical Marijuana Program (MMP), with a focus on ways to expand access to marijuana for medical purposes. These include, but are not limited to, a review of the current rules for operations and siting of dispensaries and cultivation facilities; conditions for participating physicians in the program; the current list of debilitating medical conditions for which medical marijuana may be authorized pursuant to N.J.S.A. 24:6I-3; physician flexibility to make determinations about qualifying conditions; methods by which patients and caregivers obtain product; forms for medical marijuana to be ingested, taking into consideration the needs for different methods for different patients; and other aspects of the MMP within the Department discretion that hinder or fail to effectively achieve the statutory objective of ensuring safe access to medical marijuana for all patients in need.
The Department of Health, after consultation with stakeholders and the Alternate Treatment Center (ATC) operators, presents the following action items and recommendations to improve and expand patient access to medicinal marijuana.3
DEPARTMENT ACTION ITEMS
EXPANSION OF AUTHORIZED DEBILITATING MEDICAL CONDITIONS
The Commissioner concurs with the October 25, 2017 final recommendation of the Medicinal Marijuana Review Panel to grant the petitions under the categories of Chronic Pain Related to Musculoskeletal Disorders, Migraine, Anxiety, Chronic Pain of Visceral Origin, and Tourette’s Syndrome.
A final agency decision was issued on March 22, 2018 to accept the Panel’s recommendations to effectuate the addition of these debilitating conditions.
DEVELOPMENT OF PATIENT, CAREGIVER, AND PHYSICIAN MOBILE ACCESS PORTAL
The Department recognizes the need to provide a more convenient technology experience for patients, caregivers, and physicians. The Department will develop and implement a comprehensive updated program portal, which will include the ability to securely upload documents and submit payments using a smartphone or tablet, with a target implementation date of Spring 2019.
In an interim measure, Department IT staff have been able to provide access via mobile device to the current registry and payment processing system. This access will go live in Spring 2018 and provide expanded patient access to the registry.
REGULATORY ACTION ITEMS
REDUCE REGISTRATION FEES
The Department plans to revise N.J.A.C. 8:64-2.1(1)(c) to reduce registration fees. Currently, the fee for issuance or renewal of an MMP registry identification card is $200, with a reduced card fee of $20 for those receiving
1 The recommendations made in this Executive Summary are presented in tabular form in Attachment A, Executive Summary Matrix, attached to this report.
2 Executive Order 6 also directed the Board of Medical Examiners to conduct the same review; however, the Board has advised that its recommendations will be provided under separate cover.
3 Please note that the Department may consider additional programmatic changes through the regulatory process, which is subject to public comment pursuant to N.J.A.C. 1:30-5.4.
page3image27576 page3image28160 page3image28584 page3image28744 page3image29328 page3image30232 page3image30816 page3image31400 page3image31560 page3image32144 page3image33048 page3image33632 page3image34216 page3image34376 page3image34536
Page 3
certain forms of public assistance.4 The Department will expand the reduced card fee to senior citizens and military veterans,5 and continue the reduced card fee for those receiving public assistance. Additionally, the Department will reduce the registration fee for all other qualifying patients and caregivers to $100 for the issuance or renewal of a registry identification card, which is valid for a two-year period.
In advance of the formal rulemaking process, the Department will begin charging these reduced registration fees to qualifying patients to alleviate the financial burden on patients.
PERMIT SATELLITE ATC LOCATIONS
The Department plans to amend N.J.A.C. 8:64-7.9 to permit current ATCs to dispense at satellite locations and permit more than one cultivation site per ATC with Department approval. Additional sites will be subject to all applicable laws, rules and local ordinances. The goal of eliminating the prohibition on satellite sites is to allow for increase in supply of, and access to, product for qualifying patients.
In advance of the formal rulemaking process, the Department will consider waivers of N.J.A.C. 8:64-7.9 from ATCs on a case-by-case basis.
ELIMINATE THE PHYSICIAN REGISTRY
The Department plans to eliminate N.J.A.C. 8:64-2.4 and revise associated rules, which requires physicians interested in providing care to MMP patients to first register with the Department. In turn, these physicians were listed on the Department’s public website in a physician registry for patient convenience. The Department’s elimination of the physician registry will permit any New Jersey physician in good standing and in possession of an active controlled dangerous substances registration issued by the State Division of Consumer Affairs to authorize medicinal marijuana for their qualifying patients. The Department recognizes that not every physician eligible to authorize medicinal marijuana will choose to do so; therefore, the Department will continue to publish a list of physicians who are interested in providing care to qualifying MMP patients. These physician listings will be done on an optional basis as a convenience to patients.
In advance of the formal rulemaking process, the Department will begin the transition in Spring 2018 to eliminate the current physician registry procedure. This will allow program and IT staff to begin the review and potential reengineering of business processes to streamline the experience for patients, physicians, and program once the new portal is up and running. The portal would be rolled out in a series of modules next year.
STREAMLINE PROCESS FOR ADDITION OF DEBILITATING CONDITIONS
The Department plans to revise N.J.A.C. 8:64-5.2 and -5.3, which created a petition process and review panel to make recommendations for the approval of additional debilitating medical conditions. The Medicinal Marijuana Review Panel serves a vital role in the review and recommendation of additional debilitating medical conditions. The Panel will continue to serve the Department in an advisory capacity; however, the Department will streamline the petition and panel process by removing the requirement in N.J.A.C. 8:64-5.3 that petitions for the addition of debilitating conditions be referred to the Medicinal Marijuana Review Panel. This will allow for the Commissioner to add debilitating conditions in extraordinary circumstances without a lengthy review process. These proposed
4 Qualifying patients who receive New Jersey Medicaid, food stamps, temporary disability insurance (TDI), or Federal Supplemental Security Income (SSI) or Social Security Disability (SSD) benefits are eligible for the reduced fee.
5 The U.S. Department of Veterans Affairs revised its policy with respect to medical marijuana in late 2017. The policy urges government physicians to "discuss with the Veteran marijuana use, due to its clinical relevance to patient care, and discuss marijuana use with any Veterans requesting information about marijuana." The full policy can be found on the VA website at https://www.publichealth.va.gov/marijuana.asp. In addition, states such as Massachusetts have implemented fee waivers for veterans and other states with medicinal marijuana programs have reduced registration fees for veterans.
page4image31600 page4image31760 page4image31920 page4image32080 page4image32240 page4image32400 page4image32560 page4image32720 page4image32880 page4image33040
Page 4
revisions will eliminate bureaucratic barriers for patients in need whose illnesses are not included in the current list of debilitating conditions already covered by the program.
ALLOW TWO CAREGIVERS PER PATIENT
The Department plans to revise N.J.A.C. 8:64-1.2 and associated rules to allow designation of a second primary caregiver who will be subject to the same requirements as the primary caregiver. This revision will reduce the burdens on primary caregivers and further ensure that qualifying patients are able to continuously obtain product.
In advance of the formal rulemaking process, the Department will lift the one-person limit on primary caregiver designation and allow two primary caregivers upon request.
CREATE SEPARATE ENDORSEMENTS FOR ATC PERMITS
The Department plans to revise N.J.A.C. 8:64-7.1 and associated rules to create an endorsement system within the ATC permitting process. These endorsements would allow ATCs to engage in one or more of the following activities related to the provision of usable marijuana to qualifying patients: 1) cultivation and harvesting usable marijuana; 2) manufacturing and processing usable marijuana (including the manufacturing of edible products); and 3) dispensing of usable marijuana. The Department envisions that existing ATCs would receive some combination of production, cultivation, and dispensing endorsements under this new system, which will be set forth in regulation. Once approved through regulation, this endorsement system would permit an increase in the available supply of, and access to, usable marijuana to mitigate patient supply issues and promote a more diverse workforce and industry dedicated to the provision of medicinal marijuana. It is anticipated that this separate endorsement system will be utilized in a future Request for Applications to solicit applicants for ATC permits.
ELIMINATE 10% THC LIMIT
The Department plans to repeal N.J.A.C. 8:64-10.7(c) to remove the 10% THC limit for product sold. The 10% THC limit was implemented at MMP inception to ensure that doctors and their patients had a reliable and standardized choice of potency options from which to choose and to provide patients with effective medicine to start. The Department committed to evaluate the THC limit as the program evolved. Minnesota conducted an analysis of the effects of THC doses to treat conditions approved for medicinal marijuana under its program, finding that higher potency THC treatments provided effective treatment for a number of conditions.6 Upon further evaluation, the Department will eliminate the THC limit to allow for more effective treatment of the debilitating medical conditions covered under the State’s program.
ELIMINATE PSYCHIATRIST EVALUATION FOR MINORS
The Department plans to revise N.J.A.C. 8:64-2.5 to remove the requirement for “written confirmation from a physician trained in the care of pediatric patients and from a psychiatrist” for a physician to authorize the use of medicinal marijuana for a minor. In the event that physicians need to seek consultation from another provider, this can be done in the regular course of care. This requirement creates an artificial barrier to care, as there should be parity in the treatment of patients, regardless of age.
STATUTORY RECOMMENDATIONS
While amendments to statute are beyond the Department’s authority, the following provisions of the Compassionate Use Medical Marijuana Act (Act or CUMMA) restrict the ability to expand safe access to medical
6 The study entitled “A Review of Medical Cannabis Studies Linked to Chemical Compositions and Dosages for Qualifying Medical Conditions” can be found at http://www.health.state.mn.us/topics/cannabis/practitioners/dosagesandcompositions2017.pdf
page5image28336 page5image28496 page5image28656 page5image28816 page5image28976 page5image29136 page5image29296 page5image29456 page5image31104 page5image31688 page5image32112 page5image32272
Page 5
marijuana for all patients in need. The Department recommends working with the Legislature to propose the following statutory changes.
ALLOW EDIBLES FOR ALL PATIENTS
N.J.S.A. 24:6I-7(a) restricts use of edible products to qualifying patients who are minors; however, this product type should be permissible for all patients. The ingestion of medicinal marijuana is healthier for patients than smoking. While some manufactured products such as topicals and lozenges are available for adults, patients with dexterity issues or who have difficulty following dosage instructions would benefit from the use of edibles.
ALLOW PATIENT TO REGISTER AT MORE THAN ONE ATC
N.J.S.A. 24:6I-10(d) states that patients “shall be registered to purchase usable marijuana from only one ATC at a given time.” This limits patient access to product. The Department recommends that the statute be amended to allow patients to obtain product from any State ATC dispensary.
ALLOW USE OF MARIJUANA AS A FIRST-LINE TREATMENT
N.J.S.A. 24:6I-3 stipulates that “seizure disorder, including epilepsy; intractable skeletal muscular spasticity; post- traumatic stress disorder; or glaucoma” must be “resistant to conventional medical therapy” to be considered a debilitating medical condition. The Department recommends that this caveat be deleted to permit the use of medicinal marijuana as a first-line treatment, rather than a last resort, for these conditions.
PERMIT UNLIMITED SUPPLY FOR PATIENTS RECEIVING HOSPICE CARE
As N.J.S.A. 24:6I-10(a) establishes a two-ounce limit that may be authorized by physicians in a 30-day period, this limit may be restrictive for those receiving hospice care in the final stages of life. Research in The Journal of Pain indicates that the use of medicinal marijuana is associated with improvements in pain, function, and quality of life.7 To effectively provide symptom and pain control, the maximum monthly product limit should be eliminated. The Department strongly recommends that the statutory product limit for those receiving hospice care be eliminated. This recommendation reinforces the purpose established in the enabling legislation, which “protects...those patients who use marijuana to alleviate suffering from debilitating medical conditions.”8
INCREASE MAXIMUM MONTHLY PRODUCT LIMIT
N.J.S.A. 24:6I-10(a) establishes a two-ounce limit that may be authorized by physicians in a 30-day period. Physicians should have the discretion to authorize more than two ounces. To that end, the Department recommends that the statutory limit be increased to four ounces. This recommendation is consistent with our neighboring states that have an active medicinal marijuana program. Both New York and Pennsylvania provide for a “30-day supply” without reference to amount and Delaware’s program has a six-ounce limit. However, this proposed increase in medicinal marijuana supply limits would likely need reinforcement through the revision of N.J.S.A. 24:6I-6 to ensure that patients have adequate legal protection against criminal charges.
REMOVAL OF NON-PROFIT REQUIREMENT FOR ORIGINAL ATCS
N.J.S.A. 24:6I-7(a) currently establishes that the first two alternative treatment centers issued a permit in each region shall be nonprofit entities, and centers subsequently issued permits may be nonprofit or for-profit entities. This subsection further defines the requirements of an ATC with respect to the lifecycle of supplying usable
7 This research study, Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS), is in Volume 16, Issue 12 of the Journal of Pain (December 2015). The article can be found at http://www.jpain.org/article/S1526-5900(15)00837- 8/fulltext.
8 N.J.S.A. 24:6I-2(e).
page6image28024 page6image28184 page6image28344 page6image28504 page6image28664 page6image28824 page6image28984 page6image29144 page6image29304 page6image29464 page6image29624 page6image29784 page6image29944 page6image30104 page6image30264 page6image30424 page6image30584
Page 6
marijuana to qualifying patients. The Department recommends removal of the non-profit requirement for the original alternate treatment centers to create parity among all centers.
ADDITIONAL CONSIDERATIONS
In addition to the recommendations and action items presented above, the Department is exploring the following areas to continue the expansion of patient access and elimination of bureaucratic barriers:
HOME DELIVERY
The Act provides that an ATC is “authorized to acquire a reasonable initial and ongoing inventory, as determined by the department, of marijuana seeds or seedlings and paraphernalia, possess, cultivate, plant, grow, harvest, process, display, manufacture, deliver, transfer, transport, distribute, supply, sell, or dispense marijuana, or related supplies to qualifying patients or their primary caregivers who are registered with the department.” N.J.S.A. 24:6I-7(a). However, the rules currently prohibit home delivery of product to patients or caregivers. N.J.A.C. 8:64-10.12.
The Department is currently working with external stakeholders to review delivery models that would ensure timely and accurate delivery of product to patients, driver safety, and compliance with applicable State law. We recognize that home delivery would provide an added value to MMP patients; and the Department is undertaking a deliberate and thorough review of home delivery, with the goal of removing the prohibition on home delivery.
PERMITTING EXTERNAL LABORATORIES TO CONDUCT QUALITY CONTROL TESTING
N.J.A.C. 8:64-13.4 currently requires that the Department conduct testing of samples for product quality control to ensure the safety of registered qualifying patients. With the anticipated addition of ATCs and the influx of new patients, the Department is researching the feasibility of using external laboratories to provide the required testing, with the Department acting as a secondary testing source.
The Department will continue to explore whether there are sufficient external laboratory resources qualified to supplement the testing capacity of our current State laboratory.
DEVELOPMENT OF PROVIDER EDUCATION PROGRAM AND DOSING GUIDELINES
With the expansion of authorized debilitating conditions, the Department recognizes the need to provide education and guidance to providers. To that end, the Department is exploring the creation of an education program for all physicians, with focus on the endocannabinoid system.
The Department plans to leverage the expertise of the Medicinal Marijuana Review Panel to oversee the curriculum development for this program. This education program will serve to create best practices for the safe and effective administration of medicinal marijuana to the expanded universe of qualifying patients.
In conjunction with the provider education program, there is also a need to develop standardized dosing and administrative protocols for medicinal marijuana products, including information on expected effects, side effects, and adverse effects. In addition to the provider education component above, the Department will charge the Medicinal Marijuana Review Panel, in an advisory role, to oversee the study of the efficacy of medicinal marijuana in treating New Jersey Medicinal Marijuana Program patients. This research will inform dosing and administration protocols to create best practices and improve health outcomes for qualifying patients.
The Department believes that this refocusing of the Medicinal Marijuana Review Panel will make the best use of the expertise that the Panel provides to create best practices to inform health care providers and improve health outcomes for qualifying patients.
page7image27176 page7image27760 page7image28664 page7image29248 page7image29672 page7image29832 page7image29992 page7image30152 page7image30312 page7image30472
Page 7
page8image400
ELIMINATION OF SALES TAX ON MEDICINAL MARIJUANA
Bulletin TB-68 issued on November 30, 2012 by the New Jersey Division of Taxation directs that “[r]etail sales of medical marijuana are subject to tax,” citing N.J.S.A. 54:32B-3(a), which authorizes the imposition of sales tax for retail sales. This guidance was issued despite previous Taxation guidance in Bulletin TB-63(R), issued February 16, 2010, which exempts “drugs sold pursuant to a doctor’s prescription” from the imposition of sales tax. TB-63(R) defines “drug” as “a compound, substance or preparation, and any component of a compound, substance or preparation, other than food and food ingredients, dietary supplements or alcoholic beverages, that is: (1) Recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, and supplement to any of them; or (2) Intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; or (3) Intended to affect the structure or any function of the body. Given this definition, marijuana could certainly be classified as a drug for sales tax purposes.
If the distinguishing factor is the semantic difference between “prescribing” a drug versus the dispensing of medicinal marijuana pursuant to a physician’s “authorization,” the intent of physicians in both instances is the same: to provide relief to those suffering from debilitating medical conditions.
Given the Governor’s instruction through the promulgation of Executive Order 6 to expand access and eliminate bureaucratic barriers, the Department of Health will work with the Department of the Treasury to expand the sales tax exemption for retail sales of medicinal marijuana through the issuance of revised technical guidance.
DEPARTMENT REVIEW OF ATC PERMITTING AND BACKGROUND CHECK PROCESS
The Department recognizes that the current process to obtain an ATC permit and open a dispensary is lengthy, which can have an effect on supply. This effect will be magnified by the anticipated influx of new participating patients resulting from the addition of new debilitating conditions. The Department is mindful of the balance between conducting thorough due diligence on ATC applicants while ensuring that potential permit holders are not mired down in an overly complex or burdensome application process. To strike this balance, the Department will work with the Department of Law and Public Safety to conduct a review of the current permit and background check process to create efficiencies, with the anticipated goal of implementing the new review process in the upcoming Request for Applications.
page8image20168 page8image20328
Page 8
page9image624 page9image1208
NEW JERSEY COMPASSIONATE USE MEDICAL MARIJUANA ACT
P.L. 2009, c. 307, approved January 18, 2010, and codified at N.J.S.A. 24:6I-1 et seq., is the New Jersey Compassionate Use Medical Marijuana Act (the Act). The Act is the enabling authority for the New Jersey MMP. P.L. 2013, c. 160, effective September 10, 2013, amended various sections of the Act, such as providing that alternative treatment centers (ATCs) shall not be limited in the number of strains of medical marijuana cultivated;9 that ATCs are allowed to cultivate and dispense medical marijuana in dried form, oral lozenges, topical formulations, or edible form as well as any other form as authorized by the Commissioner; that the edible form shall include tablets, capsules, drops or syrups and any other form as authorized by the Commissioner; and that the edible form10 shall be available only to qualifying patients who are minors. P.L. 2016, c. 53, effective September 14, 2016, expanded the definition of “debilitating medical condition” to include Post-Traumatic Stress Disorder and to permit individuals who suffer from Post-Traumatic Stress Disorder to qualify to obtain and use marijuana for medicinal purposes.
REGULATIONS GOVERNING THE MEDICINAL MARIJUANA PROGRAM
DEPARTMENT OF HEALTH
The Department rules governing the MMP are set forth at N.J.A.C. 8:64-1 et seq. The rules establish the process by which qualifying patients, their physicians, and their primary caregivers register with the Department to avail themselves of the Act’s protections against civil and criminal sanction. The Department rules also establish procedures for the permitting, establishment, and operation of ATCs to cultivate and dispense medicinal marijuana and related supplies.
The Department originally proposed rules for the MMP on November 15, 2010.11 Thereafter, the Legislature passed a concurrent resolution stating that certain rules were inconsistent with the intent of the Act. S. Res. 130, 214th Leg. (N.J. 2010) and Assemb. Res. 151, 214th Leg (N.J. 2010). See also 43 N.J.R. 340(a) (Feb. 22, 2011). The concurrent resolution directed the Department to amend or withdraw portions of rules that the Legislature identified as non-conforming, within thirty days. More specifically, the concurrent resolution identified as non-conforming the imposed limitation on debilitating conditions treatable by medicinal marijuana, the separation of ATC activities for cultivation and distribution of marijuana, and the limit imposed on the level of delta-9-tetrahydrocannabinol (THC) contained in marijuana products sold.
On February 22, 2011, the Department proposed modified rules.12 The new rules differed from the rules proposed at 42 N.J.R. 2668(a) by providing for 6 alternative treatment centers (ATCs) that cultivate and dispense medicinal marijuana, combining the separate application processes for cultivating and dispensing permits into one application for an ATC permit; prohibiting ATC satellite dispensing locations; prohibiting home delivery;13 and only requiring that the medical conditions originally named in the Act be resistant to conventional medical therapy in order to qualify as debilitating medical conditions for purposes of a patient obtaining a registry identification
9 Although the Department rules currently limit the number of strains of medical marijuana to three that an ATC may cultivate, N.J.A.C. 8:64-10.7(a), that provision will be repealed and has not been enforced by the Department as of the law being amended in 2013.
10 Oral lozenges are not classified as “edible form” and are available to both qualifying adult and minor patients. 11 42 N.J.R. 2668(a).
12 43 N.J.R. 340(a).
13 As explained in the Department’s Notice of Adoption, effective December 19, 2011, a bi-partisan agreement between Governor Chris Christie and Assemblyman Reed Gusciora, one of the primary sponsors of the Act, eliminated home delivery as part of an effort to reach a compromise to implement the MMP. The Notice of Adoption also explained that experience with the program would determine whether home delivery is needed in the future.
page9image32576 page9image33160 page9image33584 page9image33744 page9image34328 page9image35232 page9image35816 page9image36240 page9image36824 page9image37728 page9image38312 page9image38736 page9image38896 page9image39056
Page 9
card. A second concurrent resolution, S. Res. 151, 214th Leg (N.J. 2011) was introduced on April 11, 2011, which reaffirmed those proposed rules found to deviate from the Act's intent. However, the Legislature never adopted that resolution. The MMP rules were finalized and adopted on November 23, 2011, effective December 19, 2011.14 The Department rules are scheduled to expire on December 19, 2018.
Notably, the Department MMP rules include a provision enabling the Department to waive requirements regarding the operations of the ATC if necessary to achieve the purpose of the Act and to provide access to patients who would otherwise qualify for the use of medicinal marijuana, so long as such waiver does not create a danger to the public health, safety or welfare. N.J.A.C. 8:64-7.11.
MEDICINAL MARIJUANA PROGRAM REVIEW
The Department undertook a review of the MMP as directed by Executive Order No. 6, mindful of the limits of its respective authority under the Act. Accordingly, this report includes recommendations of what can be done to responsibly expand access to marijuana for medical purposes by way of operations and regulatory changes. The report also highlights areas where legislative change would be necessary to lift restrictions or expand the MMP.
The Act addresses the operations and siting of ATCs. Specifically, the Act states that “[t]he department shall accept applications from entities for permits to operate as [ATCs], and may charge a reasonable fee for the issuance of a permit . . . The department shall seek to ensure the availability of a sufficient number of [ATCs] throughout the State, pursuant to need, including at least two each in the northern, central, and southern regions of the State. The first two centers issued a permit in each region shall be nonprofit entities, and centers subsequently issued permits may be nonprofit or for-profit entities.” N.J.S.A. 24:6I-7.
Siting of ATCs is impacted by a regulatory prohibition on satellite locations. That is, N.J.A.C. 8:64-7.9(a) provides that “
REGULATORY ACTION ITEM: PERMIT SATELLITE ATC LOCATIONS
The Department plans to amend N.J.A.C. 8:64-7.9 to permit current ATCs to dispense at satellite locations and permit more than one cultivation site per ATC with Department approval. Additional sites will be subject to all applicable laws, rules and local ordinances. The goal of eliminating the prohibition on satellite sites is to allow for increase in supply of, and access to, product for qualifying patients.
In advance of the formal rulemaking process, the Department will consider waivers of N.J.A.C. 8:64-7.9 on a case-by-case basis.
14 43 N.J.R. 3335(a), effective Dec. 19, 2011.
page10image21912 page10image22072 page10image22656 page10image23560 page10image24144
page10image24784 page10image25368
AN EVALUATION OF THE CURRENT RULES REGULATING THE OPERATIONS AND SITING OF DISPENSARIES AND CULTIVATION FACILITIES, PARTICULARLY FOCUSING ON WHETHER THE RULES SHOULD BE REVISED TO REMOVE OBSTRUCTIONS TO EXPANSION
page10image28728 page10image29312
page10image29736 page10image29896
[t]he Department shall not authorize or permit dispensing operations at any satellite locations.
However, an ATC, as approved by the Department, may cultivate marijuana at a location separate from the
location where the ATC shall dispense the marijuana, but both locations shall be within the same region.”
page10image33960
To address the current regulatory limits to ATC expansion, the Department respectfully submits the
page10image35088
following regulatory action item:
page10image36136 page10image36296 page10image36456
P a g e 10
page11image616
Notably, siting of ATCs is subject to local ordinance. As set forth in the rules, a political
State is not prohibited from limiting the number of ATCs that may operate in the political subdivision or from
page11image3032
enacting reasonable local ordinances applicable to ATCs. N.J.A.C. 8:64-7.9(b).
page11image3960 page11image4120 page11image4544 page11image4704 page11image5128 page11image5288 page11image5448
A REVIEW OF THE CURRENT PROCESS FOR OBTAINING A LICENSE TO OPERATE A MEDICAL MARIJUANA DISPENSARY, INCLUDING RECOMMENDATIONS TO EXPEDITE THAT PROCESS
page11image7000 page11image7160 page11image7320 page11image7744 page11image7904
The Act outlines the process for obtaining a license to operate a medical marijuana dispensary. Specifically,theActprovidesthatthe“departmentshallacceptapplicationsfromentitiesforpermits to operate as alternative treatment centers, and may charge a reasonable fee for the issuance of a permit.” N.J.S.A. 24:6I-7(a). It is the Department’s statutory charge to ensure the availability of a sufficient number of ATCs throughout the State, pursuant to need, including at least two each in the northern, central, and southern regions of the State. The Act further provides that the first two centers issued a permit in each region shall be nonprofit entities, and centers subsequently issued permits may be nonprofit or for-profit entities. N.J.S.A. 24:6I- 7(a). Applicants for authorization as nonprofit ATCs shall be subject to all applicable State laws governing nonprofit entities, but need not be recognized as a 501(c)(3) organization by the federal Internal Revenue Service. Ibid.
As to the application process for operating an ATC, the Department has broad authority to require that an applicant provide such information as the department determines to be necessary pursuant to regulations. N.J.S.A. 24:6I-7(b). The Act directs the Commissioner to require each applicant seeking a permit to operate as an ATC to undergo a criminal history record background check. Owners, directors, officers, and employees of an ATC are subject to criminal background checks. N.J.S.A. 24:6I-7(d)(1). The Commissioner shall not approve an applicant for a permit to operate, or authorization to be employed at, an ATC if the criminal history record background information of the applicant reveals a disqualifying conviction under the Act. However, disqualifying convictions are subject to a clear and convincing showing of rehabilitation under certain enumerated factors. N.J.S.A. 24:6I-7(d)(6). Notably, the Commissioner has authority to offer provisional authority for employees of ATCs for a period of three months with an attestation that the individual has not been convicted of any disqualifying conviction. N.J.S.A. 24:6I-7(d)(5). Overall, the Department has broad authority to issue a permit to operate an ATC consistent with the purposes of the Act.15
The Department discharged its statutory duty to promulgate rules that created the ATC application process. Pursuant to N.J.A.C. 8:64-6.1, “the Department may periodically announce a request for applications for the award of an ATC” and the Department shall announce a request for such applications by publication in the New Jersey Register. The rule further provides for the contents of the Notice, such as eligibility criteria, evaluation criteria, weights for the criteria, applications materials, deadlines, etc. N.J.A.C. 8:64-6.1(a)-(c).
On or about January 13, 2011, the Department posted a Request for Applications (RFA) for ATC permits on its website and required that completed applications be filed by February 14, 2011. The applicant eligibility section of the RFA stated that applicants must be non-profit entities organized under the laws of the State of New Jersey because no more than six permits for ATCs would be issued at the outset. Moreover, in response to several inquiries about the RFA, the Department, on its Frequently Asked Questions (FAQ) webpage, reiterated that only non-profit applicants may apply. The Department’s decision to initially limit the number of ATC permits
15 Under the Act, the Department may suspend or revoke a permit to operate as an alternative treatment center for cause, which shall be subject to review by the Appellate Division of the Superior Court. N.J.S.A. 24:6I-7(e). There are no express penalty provisions in the Act to ensure compliance with law and regulation. This is problematic insofar as it risks availability of product to patients if the Department’s only enforcement option is the extreme measure of suspending or revoking a permit of operation to address ATC non-compliance.
subdivision of this
page11image37360 page11image37520 page11image37680 page11image37840 page11image38000 page11image38160 page11image38320 page11image38480 page11image38640 page11image38800 page11image38960
P a g e 11
to six was part of a bi-partisan agreement reached between Governor Christie and the Assembly sponsor of the Act in early December 2010.
By February 14, 2011, 21 separate entities had submitted 35 applications for ATC permits. After evaluating the applications based on criteria in the RFA, the Department awarded six permits to non-profit entities: two permits in the north region, two in the central region, and two in the south region. The Department’s determination to award no more than the statutorily prescribed minimum number of ATCs, and to decline to accept applications from for-profit entities at the outset, was upheld on appeal by the New Jersey Superior Court, Appellate Division. See Natural Medical, Inc. v. New Jersey Dep’t of Health & Sr. Servs., 428 N.J. Super. 259 (App. Div. 2012).
REGULATORY ACTION ITEM: CREATE SEPARATE ENDORSEMENTS FOR ATC PERMITS
The Department plans to revise N.J.A.C. 8:64-7.1 and associated rules to create an endorsement system within the ATC permitting process. These endorsements would allow ATCs to engage in one or more of the following activities related to the provision of usable marijuana to qualifying patients: 1) cultivation and harvesting usable marijuana; 2) manufacturing and processing usable marijuana (including the manufacturing of edible products); and 3) dispensing of usable marijuana. The Department envisions that existing ATCs would receive some combination of production, cultivation, and dispensing endorsements under this new system, which will be set forth in regulation. Once approved through regulation, this endorsement system would permit an increase in the available supply of, and access to, usable marijuana to mitigate patient supply issues and promote a more diverse workforce and industry dedicated to the provision of medicinal marijuana. It is anticipated that this separate endorsement system will be utilized in a future Request for Applications to solicit applicants for ATC permits.
To further expand patient access and ensure adequate supply, the Department recommends an open application process for parties interested in applying for one or more of the endorsement types set forth above. It should be noted that all future endorsements would be on either a non-profit or for-profit basis. This may also result in the faster processing of applications for some entities, as previous delays were caused by the program’s need to conduct significant due diligence to ensure applicant compliance with State non-profit laws.
STATUTORY RECOMMENDATION: REMOVAL OF NON-PROFIT REQUIREMENT FOR ORIGINAL ATCS
N.J.S.A. 24:6I-7(a) currently establishes that the first two alternative treatment centers issued a permit in each region shall be nonprofit entities, and centers subsequently issued permits may be nonprofit or for-profit entities. This subsection further defines the requirements of an ATC with respect to the lifecycle of supplying usable marijuana to qualifying patients. The Department recommends removal of the non-profit requirement for the original alternate treatment centers to create parity among all centers.
Under the Act, “physician” is defined as “a person licensed to practice medicine and surgery pursuant to Title 45 of the Revised Statutes with whom the patient has a bona fide physician-patient relationship and who is the primary care physician, hospice physician, or physician responsible for the ongoing treatment of a patient’s debilitating medical condition, provided, however, that such ongoing treatment shall not be limited to the provision of authorization for a patient to use medical marijuana or consultation solely for that purpose.” N.J.S.A. 24:6I-3. The Act goes on to state that, to issue a certification authorizing use of medical marijuana to a qualifying patient, a physician shall be licensed and in good standing to practice in the State. N.J.S.A. 24:6I-5(a). A physician may not authorize through certification a patient who is a minor unless the custodial parent, guardian, or person
page12image29904 page12image30064 page12image30224
The Department respectfully submits the following regulatory action item and statutory
page12image31232
recommendation to expand patient access:
page12image32000 page12image32160 page12image32320 page12image32480
page12image32920 page12image33504
AN EXAMINATION OF CONDITIONS FOR PARTICIPATING PHYSICIANS IN THE PROGRAM TO ENSURE
THAT ANY SUCH REQUIREMENTS ARE NOT NEEDLESSLY ONEROUS
page12image36664 page12image37248
page12image37672 page12image37832
P a g e 12
who has legal custody of the minor, consents in writing that the minor patient has that person’s permission for the medical use of marijuana and that the person will control the acquisition and possession of the medical marijuana and any related paraphernalia from the alternative treatment center. N.J.S.A. 24:6I-5(b).
Regulations promulgated by the Board of Medical Examiners (BME)16 set forth the requirements for physician participation in the MMP, including possession of an active controlled dangerous substances registration:
(a) A physician shall provide a certification and written instructions for a patient for the medical use of marijuana only if:
1. The physician holds an active New Jersey license in good standing issued by the Board and possesses an active controlled dangerous substances registration issued by the Division of Consumer Affairs that is not subject to limitation; and
2. The physician has a bona fide physician-patient relationship with the patient.

N.J.A.C. 13:35-7A.3. A bona fide physician-patient relationship is defined in the BME Rules as:
[A] relationship in which the physician has ongoing responsibility for the assessment, care and treatment of a patient's debilitating medical condition, consistent with the requirements of N.J.A.C. 13:35-7A.5. For purposes of this definition, "ongoing responsibility" means:
1. The physician-patient relationship has existed for at least one year;
2. The physician has seen and/or assessed the patient for the debilitating medical condition on at least four visits; or
3. The physician assumes responsibility for providing management and care of the patient's debilitating medical condition after conducting a comprehensive medical history and physical examination, including a personal review of the patient's medical record maintained by other treating physicians reflecting the patient's reaction and response to conventional medical therapies.

N.J.A.C. 13:35-7A.2; see also N.J.S.A. 24:6I-3 (“Bona fide physician-patient relationship” means a relationship in which the physician has ongoing responsibility for the assessment, care and treatment of a patient’s debilitating medical condition.”); N.J.A.C. 8:64-1.2 ("Bona fide physician-patient relationship" means a relationship in which the physician has ongoing responsibility for the assessment, care and treatment of a patient's debilitating medical condition consistent with the requirements of the Act and N.J.A.C. 13:35-7A.”).
Physicians and alternative treatment centers are required to transmit information to ensure the confidentiality of patient information in compliance with all Federal and State laws, rules and regulations, including the Federal Health Insurance Portability and Accountability Act of 1996, PL 104-191. N.J.A.C. 13:45A- 33.5(c).
While there are 523 MMP-approved physicians throughout the State (as of February 15, 2018), only 79% are actively writing patient statements and treating patients. Since March 2017, the program has gained 9,292 patients, or an average of 774 per month. As of February 15, 2018, there are 17,806 patients with active registry cards. Patients currently may ask their primary physician to register with the MMP or they may locate a participating physician on the website by county and/or medical specialty.
16 The Department is including BME rules for reference; however, recommendations to revise regulations to expand patient access and eliminate bureaucratic barriers are limited to those within the Department’s purview.
page13image26120 page13image26280 page13image26440 page13image26600 page13image26760 page13image26920 page13image27080 page13image27240 page13image27400 page13image27560
P a g e 13
All registered physicians are listed on the MMP website. The website currently features “Find a Doctor” through which patients can search on the internet by specialty, name or city for a physician participating in the MMP. The link can be found at http://www.nj.gov/health/medicalmarijuana/patients/find-doctor/.
DEPARTMENT ACTION ITEM: DEVELOPMENT OF PATIENT, CAREGIVER, AND PHYSICIAN MOBILE ACCESS PORTAL
The Department recognizes the need to provide a more convenient technology experience for patients, caregivers, and physicians. The Department will develop and implement a comprehensive updated program portal, which will include the ability to securely upload documents and submit payments using a smartphone or tablet, with a target implementation date of Spring 2019.
In an interim measure, Department IT staff have been able to provide access via mobile device to the current registry and payment processing system. This access will go live in Spring 2018 and provide expanded patient access to the registry.
REGULATORY ACTION ITEM: ELIMINATE THE PHYSICIAN REGISTRY
The Department plans to eliminate N.J.A.C. 8:64-2.4, which requires physicians interested in providing care to MMP patients to first register with the Department. In turn, these physicians were listed on the Department’s public website in a physician registry for patient convenience. The Department’s elimination of the physician registry will permit any New Jersey doctor meeting the requirements in N.J.A.C. 8:64-2.5 to authorize medicinal marijuana for their patients meeting the program requirements. The Department recognizes that not every physician eligible to authorize medicinal marijuana will choose to do so; therefore, the Department will continue to publish a list of physicians who are interested in providing care to qualifying MMP patients. These physician listings will be done on an optional basis as a convenience to patients.
In advance of the formal rulemaking process, the Department will begin the transition in Spring 2018 to eliminate the current physician registry procedure. This will allow program and IT staff to begin the review and potential reengineering of business processes to streamline the experience for patients, physicians, and program once the new portal is up and running. The portal would be rolled out in a series of modules next year.
REGULATORY ACTION ITEM: ELIMINATE PSYCHIATRIST EVALUATION FOR MINORS
The Department plans to revise N.J.A.C. 8:64-2.5 to remove the requirement for “written confirmation from a physician trained in the care of pediatric patients and from a psychiatrist” for a physician to authorize the use of medicinal marijuana for a minor. In the event that physicians need to seek consultation from another provider, this can be done in the regular course of care. This requirement creates an artificial barrier to care, as there should be parity in the treatment of patients, regardless of age.
The Act and rules define “debilitating medical condition” as follows:
1) one of the following conditions, if resistant to conventional medical therapy: seizure disorder,
including epilepsy; intractable skeletal muscular spasticity; or glaucoma;
page14image24240 page14image24400
To address the current requirements imposed on participating physicians, the Department respectfully
page14image25448
submits the following departmental and regulatory action items and statutory recommendation:
page14image26456 page14image26616 page14image26776 page14image26936 page14image27096 page14image27256
AN ANALYSIS OF THE CURRENT LIST OF DEBILITATING MEDICAL CONDITIONS FOR WHICH MEDICAL MARIJUANA MAY BE AUTHORIZED PURSUANT TO N.J.S.A. 24:61-3, AND A RECOMMENDATION AS TO WHETHER DOCTORS SHOULD BE GIVEN FLEXIBILITY TO MAKE THESE DETERMINATIONS ON THEIR OWN
page14image31744 page14image32544 page14image33128
P a g e 14
  1. 2)  one of the following conditions, if severe or chronic pain, severe nausea or vomiting, cachexia, or wasting syndrome results from the condition or treatment thereof: positive status for human immunodeficiency virus, acquired immune deficiency syndrome, or cancer;
  2. 3)  amyotrophic lateral sclerosis, multiple sclerosis, terminal cancer, muscular dystrophy, or inflammatory bowel disease, including Crohn’s disease;
  3. 4)  terminal illness, if the physician has determined a prognosis of less than 12 months of life; or
  4. 5)  any other medical condition or its treatment that is approved by the department by regulation.
N.J.S.A. 24:6I-3; N.J.A.C. 8:64-1.2. The Department rules also set forth a petition and panel review process by which additional debilitating medical conditions may be added for purposes of patient participation in the MMP. In summary, the Department publishes notice that it will be accepting petitions; the Commissioner appoints a medical review panel (Panel)17 to make recommendations to the Commissioner for approval or denial of those petitions; the Panel makes an initial recommendation to the Commissioner; the Panel’s recommendation is posted for a 60-day public comment period and subject to a public hearing; the Panel determines whether, based on public input, any changes should be made before making its final recommendation to the Commissioner; and the Commissioner renders a final agency determination as to whether to grant or deny the petition. N.J.A.C. 8:64-5.1 through -5.4.
In February 2016, then-Commissioner Cathleen D. Bennett appointed individuals to serve on the Panel18 for a term of three years. Thereafter, the Department published a notice in the New Jersey Register that it would be accepting petitions for additional conditions to be added to the MMP.19 The Department reviewed petitions for completeness according to rules and then submitted forty-five petitions to the Panel for review. The Panel evaluated each petition and grouped them according to seven categories. On July 21, 2017, the Panel submitted its Initial Recommendation to the Commissioner. The Panel recommended that the Commissioner grant the petitions listed under five of the seven categories: chronic pain related to musculoskeletal disorders, migraine, anxiety, chronic pain of visceral origin, and Tourette’s Syndrome. The Panel recommended that Commissioner deny petitions listed under the two remaining categories of Asthma and Chronic Fatigue. Following public comment and a public hearing, the Panel adopted its Initial Recommendation unchanged as its Final Recommendation to Commissioner on October 25, 2017.20 The Commissioner has reviewed and concurs with the Final Recommendation of the Panel.
To move forward on the addition of the identified debilitating conditions, the Department respectfully submits the following action item:
17 "Review panel" means a panel of health care professionals appointed by the Commissioner to review petitions and make recommendations for identification and approval of additional debilitating medical conditions. N.J.A.C. 8:64-1.2. The Panel shall consist of not more than 15 health care professionals, among whom shall be the President of the Board of Medical Examiners or the President's designee and other physicians as well as non-physicians who are knowledgeable about the condition as to which the petition seeks approval. Each physician appointed to the review panel shall be nationally board- certified in his or her area of specialty. At least three physicians appointed to the review panel shall have expertise in pain and symptom management. A majority of the panel shall be physicians. N.J.A.C. 8:64-5.2(b); (c).
18 The Panel is made up of the following individuals: Alex Bekker, M.D., Ph.D.– Chairperson; Cheryl Kennedy, M.D.- Vice Chairperson; Mary Bridgeman, Pharm. D.; Mary Johansen, Ph. D., NE-BC, R.N.; Petros Levounis, M.D., M.A.; Jessica Scerbo, M.D.; and Stephanie Zarus, Pharm. D.
19 48 N.J.R. 1395(a).
20 The Panel’s Initial/Final Recommendation is available at: http://www.nj.gov/health/ medicalmarijuana/documents/Initial%20Recommendation%20Letter.pdf.
page15image30368 page15image30528 page15image30688 page15image30848 page15image31008 page15image31168 page15image31328
P a g e 15
page16image600
DEPARTMENT ACTION ITEM: EXPANSION OF AUTHORIZED DEBILITATING MEDICAL CONDITIONS
The Commissioner concurs with the October 25, 2017, final recommendation of the Medicinal Marijuana Review Panel to grant the petitions under the categories of Chronic Pain Related to Musculoskeletal Disorders, Migraine, Anxiety, Chronic Pain of Visceral Origin, and Tourette’s Syndrome.
A final agency decision was issued on March 22, 2018 to accept the Panel’s recommendations to effectuate the addition of these debilitating conditions.
The Department respectfully submits the following regulatory action item and statutory recommendation to provide additional flexibility:
REGULATORY ACTION ITEM: STREAMLINE PROCESS FOR ADDITION OF DEBILITATING CONDITIONS
The Department plans to revise N.J.A.C. 8:64-5.2 and -5.3, which created a petition process and review panel to make recommendations for the approval of additional debilitating medical conditions. The Medicinal Marijuana Review Panel serves a vital role in the review and recommendation of additional debilitating medical conditions. The Panel will continue to serve the Department in an advisory capacity; however, the Department will streamline the petition and panel process by removing the requirement in N.J.A.C. 8:64-5.3 that petitions for the addition of debilitating conditions be referred to the Medicinal Marijuana Review Panel. This will allow for the Commissioner to add debilitating conditions in extraordinary circumstances without a lengthy review process. These proposed revisions will eliminate bureaucratic barriers for patients in need whose illnesses are not included in the current list of debilitating conditions already covered by the program.
STATUTORY RECOMMENDATION: ALLOW USE OF MARIJUANA AS A FIRST-LINE TREATMENT
N.J.S.A. 24:6I-3 stipulates that “seizure disorder, including epilepsy; intractable skeletal muscular spasticity; post- traumatic stress disorder; or glaucoma” must be “resistant to conventional medical therapy” to be considered a debilitating medical condition. The Department recommends that this caveat be deleted to permit the use of medicinal marijuana as a first-line treatment, rather than a last resort, for these conditions.
PATIENT AND PRIMARY CAREGIVER REGISTRATION.
The Act provides that the Department shall establish a registry of qualifying patients and their primary caregivers who shall be issued a registry identification card that is valid for two years. N.J.S.A. 24:6I-4(a). The Act provides a 30-day timeframe for approval or denial of a completed application, and a 5-day timeframe from approval to issue or renewal of the registration card. N.J.S.A. 24:6I-4(b). Primary caregivers must undergo a background check. N.J.S.A. 24:6I-4(c)(1). The Act also provides that primary caregivers may not serve in that capacity for more than one qualifying patient. N.J.S.A. 24:6I-3.
By rule, the patient and primary caregiver MMP registration fee is $200.00 for two years. N.J.A.C. 8:64- 2.1(c). Patients and caregivers that receive New Jersey Medicaid, Supplemental Nutrition Assistance Program (SNAP) benefits, New Jersey Temporary Disability Insurance benefits, Supplemental Security Income (SSI) benefits or Social Security Disability (SSD) benefits, receive a reduced registration fee of $20.00. N.J.A.C. 8:64-2.1(c)(1). Approximately 18% percent of registered patients and caregivers receive the reduced application fee of $20.00.
page16image24864 page16image25024 page16image25184 page16image25344 page16image25504
page16image25880 page16image26464
AN ASSESSMENT OF THE METHODS THROUGH WHICH PATIENTS OR THEIR PRIMARY CAREGIVERS ARE OBTAINING MEDICAL MARIJUANA AND A RECOMMENDATION OF WHETHER RULES SHOULD BE AMENDED TO APPROVE ADDITIONAL METHODS THAT COULD FACILITATE PATIENT ACCESS
page16image29984 page16image30568
page16image30992 page16image31576 page16image32480 page16image33064 page16image33488 page16image33648 page16image33808 page16image33968 page16image34128 page16image34288 page16image34448
In addition to the development of the mobile access portal previously discussed, the Department
page16image35576
respectfully submits the following regulatory action items to facilitate the patient registration experience to
page16image36704
reduce costs and ensure continuity of care:
P a g e 16
page17image568
REGULATORY ACTION ITEM: REDUCE REGISTRATION FEES
The Department plans to revise N.J.A.C. 8:64-2.1(1)(c) to reduce registration fees. Currently, the fee for issuance or renewal of an MMP registry identification card is $200, with a reduced card fee of $20 for those receiving certain forms of public assistance.21 The Department will expand the reduced card fee to senior citizens and military veterans,22 and continue the reduced card fee for those receiving public assistance. Additionally, the Department will reduce the registration fee for all other qualifying patients and caregivers to $100 for the issuance or renewal of a registry identification card, which is valid for a two-year period.
In advance of the formal rulemaking process, the Department will begin charging reduced registration fees to qualifying patients to alleviate the financial burden on patients.
REGULATORY ACTION ITEM: ALLOW TWO CAREGIVERS PER PATIENT
The Department plans to revise N.J.A.C. 8:64-1.2 and associated provisions to include a second “primary caregiver,” who will be subject to the same requirements as the primary caregiver.23 This revision will reduce the burdens on primary caregivers and further ensure that qualifying patients are able to continuously obtain product.
In advance of the formal rulemaking process, the Department will lift the one-person limit on primary caregiver designation and allow two primary caregivers upon request.
MEDICAL MARIJUANA DISPENSING
The Act limits the quantity of product that a patient can obtain in a 30-day period. Specifically, a physician shall provide written instructions for a registered qualifying patient or his caregiver to present to an ATC concerning the total amount of usable marijuana that a patient may be dispensed, in weight, in a 30-day period, which amount shall not exceed two ounces. N.J.S.A. 24:6I-10(a). A physician may issue multiple written instructions at one time authorizing the patient to receive a total of up to a 90-day supply, subject to certain conditions. N.J.S.A. 24:6I-10(b).
The rules provide that the maximum THC24 content of any sold product shall not exceed 10 percent. N.J.A.C. 8:64-10.7.
REGULATORY ACTION ITEM: ELIMINATE 10% THC LIMIT
The Department plans to repeal N.J.A.C. 8:64-10.7(c) to remove the 10% THC limit for product sold. The 10% THC limit was implemented at MMP inception to ensure that doctors and their patients had a reliable and standardized choice of potency options from which to choose and to provide patients with effective medicine to start. The
21 Qualifying patients who receive New Jersey Medicaid, food stamps, temporary disability insurance (TDI), or Federal Supplemental Security Income (SSI) or Social Security Disability (SSD) benefits are eligible for the reduced fee.
22 The U.S. Department of Veterans Affairs revised its policy with respect to medical marijuana in late 2017. The policy urges government physicians to "discuss with the Veteran marijuana use, due to its clinical relevance to patient care, and discuss marijuana use with any Veterans requesting information about marijuana." The full policy can be found on the VA website at https://www.publichealth.va.gov/marijuana.asp. In addition, states such as Massachusetts have implemented fee waivers for veterans and other states with medicinal marijuana programs have reduced registration fees for veterans.
23 The Act prohibits a primary caregiver from serving more than one patient at a time but it does not prohibit multiple primary caregivers for one patient.
24 THC, or delta-9-tetrahydrocannabinol, is the principal psychoactive constituent of cannabis.
page17image28392 page17image28552 page17image28712 page17image28872 page17image29456 page17image30360 page17image30944 page17image31368 page17image31528 page17image31688 page17image31848
The Department respectfully submits the following regulatory action item and statutory
page17image32856
recommendations with respect to expanding patient access with respect to product dispensing:
page17image33904 page17image34064 page17image34224 page17image34384
P a g e 17
Department committed to evaluate the THC limit as the program evolved. Minnesota conducted an analysis of the effects of THC doses to treat conditions approved for medicinal marijuana under its program, finding that higher potency THC treatments provided effective treatment for a number of conditions. Upon further evaluation, the Department will eliminate the THC limit to allow for more effective treatment of the debilitating medical conditions covered under the State’s program.
STATUTORY RECOMMENDATION: PERMIT UNLIMITED SUPPLY FOR PATIENTS RECEIVING HOSPICE CARE
As N.J.S.A. 24:6I-10(a) establishes a two-ounce limit that may be authorized by physicians in a 30-day period, this limit may be restrictive for those receiving hospice care in the final stages of life. Research in The Journal of Pain indicates that the use of medicinal marijuana is associated with improvements in pain, function, and quality of life.25 To effectively provide symptom and pain control, the maximum monthly product limit should be eliminated. The Department strongly recommends that the statutory product limit for those receiving hospice care be eliminated. This recommendation reinforces the purpose established in the enabling legislation, which “protects...those patients who use marijuana to alleviate suffering from debilitating medical conditions.”26
STATUTORY RECOMMENDATION: INCREASE MAXIMUM MONTHLY PRODUCT LIMIT
N.J.S.A. 24:6I-10(a) establishes a two-ounce limit that may be authorized by physicians in a 30-day period. Physicians should have the discretion to authorize more than two ounces. To that end, the Department recommends that the statutory limit be increased to four ounces. This recommendation is consistent with our neighboring states that have an active medicinal marijuana program. Both New York and Pennsylvania provide for a “30-day supply” without reference to amount and Delaware’s program has a six-ounce limit. However, this proposed increase in medicinal marijuana supply limits would likely need reinforcement through the revision of N.J.S.A. 24:6I-6 to ensure that patients have adequate legal protection against criminal charges.
STATUTORY RECOMMENDATION: ALLOW PATIENTS TO REGISTER AT MORE THAN ONE ATC
N.J.S.A. 24:6I-10(d) stipulates that patients “shall be registered to purchase usable marijuana from only one ATC at a given time.” This limits patient access to product. The Department recommends that the statute be amended to allow patients to obtain product from any State ATC dispensary.
As noted above, the Act was amended in 2013 to expand the permissible forms of medicinal marijuana. The Act currently provides that an ATC may package and directly dispense marijuana to qualifying patients in dried form, oral lozenges, topical formulations, or edible form, or any other form as authorized by the Commissioner. Edible form shall include tablets, capsules, drops or syrups and any other form as authorized by the Commissioner. Notably, the Act limits availability of edible forms to qualifying patients who are minors. N.J.S.A. 24:6I-7(a).
The Department rules provide that an ATC shall package or dispense marijuana in: 1. Dried form for direct dispensing to qualifying patients;
2. Oral lozenges for direct dispensing to qualifying patients; or
3. Topical formulations for direct dispensing to qualifying patients.

25 This research study, Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS), is in Volume 16, Issue 12 of the Journal of Pain (December 2015). The article can be found at http://www.jpain.org/article/S1526-5900(15)00837- 8/fulltext.
26 N.J.S.A. 24:6I-2(e).
page18image27008 page18image27168 page18image27328 page18image27488 page18image27648 page18image27808 page18image27968
page18image28344 page18image28928
A REVIEW OF REGULATIONS THAT GOVERN THE FORMS IN WHICH MEDICAL MARIJUANA CAN BE INGESTED, TAKING INTO CONSIDERATION THE NEEDS FOR DIFFERENT METHODS FOR DIFFERENT PATIENTS
page18image32128 page18image32712
page18image33136 page18image33296 page18image33456 page18image33616 page18image33776
P a g e 18
N.J.A.C. 8:64-10.8(e). Although the Department rules do not yet reflect the Act’s 2013 amendments as to “edible form,” the Department has allowed the manufacturing and dispensing by ATCs of product in all forms as permitted by law. There are currently two ATCs that provide manufactured products to qualifying patients. It should be noted that the Department does not mandate that ATCs provide marijuana in topical or edible formulations, as it is an individual business decision made by each ATC. In fact, the Department issued standards governing the manufacturing of lozenges, topical formulations and edible form products by ATCs in March 2015. The standards were issued to help ensure that ATCs provide patients with products that are of acceptable and consistent in strength, quality, and purity. In addition, the standards sought to ensure the safety of ATC employees working in the manufacturing process.
In summary, the Department allows all forms of medical marijuana permitted by law and ATCs make their own business decisions as to production of dried product, oral lozenges, topical formulations, or edible forms.
STATUTORY RECOMMENDATION: ALLOW EDIBLES FOR ALL PATIENTS
N.J.S.A. 24:6I-7(a) restricts use of edible products to qualifying patients who are minors; however, this product type should be permissible for all patients. The ingestion of medicinal marijuana is healthier for patients than smoking. While some manufactured products such as topicals and lozenges are allowed for adults, patients with dexterity issues or who have difficulty following dosage instructions would benefit from the use of edibles.
ADDITIONAL CONSIDERATIONS
In addition to the recommendations and action items presented above, the Department is exploring the following areas to continue the expansion of patient access and elimination of bureaucratic barriers:
HOME DELIVERY
The Act provides that an ATC is “authorized to acquire a reasonable initial and ongoing inventory, as determined by the department, of marijuana seeds or seedlings and paraphernalia, possess, cultivate, plant, grow, harvest, process, display, manufacture, deliver, transfer, transport, distribute, supply, sell, or dispense marijuana, or related supplies to qualifying patients or their primary caregivers who are registered with the department.” N.J.S.A. 24:6I-7(a). However, the rules currently prohibit home delivery of product to patients or caregivers. N.J.A.C. 8:64-10.12.
The Department is currently working with external stakeholders to review delivery models that would ensure timely and accurate delivery of product to patients, driver safety, and compliance with applicable State law. We recognize that home delivery would provide an added value to MMP patients; and the Department is undertaking a deliberate and thorough review of home delivery, with the goal of removing the prohibition on home delivery.
PERMITTING EXTERNAL LABORATORIES TO CONDUCT QUALITY CONTROL TESTING
N.J.A.C. 8:64-13.4 currently requires that the Department conduct testing of samples for product quality control to ensure the safety of registered qualifying patients. With the anticipated addition of ATCs and the influx of new patients, the Department is researching the feasibility of using external laboratories to provide the required testing, with the Department acting as a secondary testing source.
page19image25368
Although the Executive Order charges the Department with a review of the regulations governing the
forms of medical marijuana available for patients, the Department is constrained by the current statutory restriction on the availability of edible forms of marijuana for adult patients. To that end, the Department
respectfully submits the following statutory recommendation with respect to expanding patient access to all
forms of medical marijuana:
page19image30672 page19image30832 page19image30992 page19image31576 page19image32480 page19image33064 page19image33488 page19image33648 page19image33808 page19image33968 page19image34128
P a g e 19
The Department will continue to explore whether there are sufficient external laboratory resources qualified to supplement the current testing capacity of our State laboratory.
DEVELOPMENT OF PROVIDER EDUCATION PROGRAM AND DOSING GUIDELINES
With the expansion of authorized debilitating conditions, the Department recognizes the need to provide education and guidance to providers. To that end, the Department is exploring the creation of an education program for all physicians, with focus on the endocannabinoid system.
The Department plans to leverage the expertise of the Medicinal Marijuana Review Panel to oversee the curriculum development for this program. This education program will serve to create best practices for the safe and effective administration of medicinal marijuana to the expanded universe of qualifying patients.
In conjunction with the provider education program, there is also a need to develop standardized dosing and administrative protocols for medicinal marijuana products, including information on expected effects, side effects, and adverse effects. In addition to the provider education component above, the Department will charge the Medicinal Marijuana Review Panel, in an advisory role, to oversee the study of the efficacy of medicinal marijuana in treating New Jersey Medicinal Marijuana Program patients. This research will inform dosing and administration protocols to create best practices and improve health outcomes for qualifying patients.
The Department believes that this refocusing of the Medicinal Marijuana Review Panel will make the best use of the expertise that the Panel provides to create best practices to inform health care providers and improve health outcomes for qualifying patients.
ELIMINATION OF SALES TAX ON MEDICINAL MARIJUANA
Bulletin TB-68 issued on November 30, 2012 by the New Jersey Division of Taxation directs that “[r]etail sales of medical marijuana are subject to tax,” citing N.J.S.A. 54:32B-3(a), which authorizes the imposition of sales tax for retail sales. This guidance was issued despite previous Taxation guidance in Bulletin TB-63(R), issued February 16, 2010, which exempts “drugs sold pursuant to a doctor’s prescription” from the imposition of sales tax. TB-63(R) defines “drug” as “a compound, substance or preparation, and any component of a compound, substance or preparation, other than food and food ingredients, dietary supplements or alcoholic beverages, that is: (1) Recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, and supplement to any of them; or (2) Intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; or (3) Intended to affect the structure or any function of the body. Given this definition, marijuana could certainly be classified as a drug for sales tax purposes.
If the distinguishing factor is the semantic difference between “prescribing” a drug versus the dispensing of medicinal marijuana pursuant to a physician’s “authorization,” the intent of physicians in both instances is the same: to provide relief to those suffering from debilitating medical conditions.
Given the Governor’s instruction through the promulgation of Executive Order 6 to expand access and eliminate bureaucratic barriers, the Department of Health will work with the Department of the Treasury to expand the sales tax exemption for retail sales of medicinal marijuana through the issuance of revised technical guidance.
DEPARTMENT REVIEW OF ATC PERMITTING AND BACKGROUND CHECK PROCESS
The Department recognizes that the current process to obtain an ATC permit and open a dispensary is lengthy, which can have an effect on supply. This effect will be magnified by the anticipated influx of new participating patients resulting from the addition of new debilitating conditions. The Department is mindful of the balance between conducting thorough due diligence on ATC applicants while ensuring that potential permit holders are not mired down in an overly complex or burdensome application process. To strike this balance, the Department will work with the Department of Law and Public Safety to conduct a review of the current permit and
page20image31472 page20image31632 page20image31792 page20image31952
P a g e 20
background check process to create efficiencies, with the anticipated goal of implementing the new review process in the upcoming Request for Applications.
CONCLUSION
The Department of Health respectfully submits this report pursuant to Executive Order No. 6 (2018).
page21image2912 page21image3496 page21image4400 page21image4984
P a g e 21
page22image456 page22image1040
ATTACHMENTS
page22image2392 page22image2976
Executive Summary Matrix Executive Order 6
P a g e 22
Attachment A: Executive Summary Matrix
page23image2040 page23image2200 page23image2360 page23image2520
Item Description
Estimated Timeframe for Implementation *
Operational Actions
Regulatory Actions
Statutory Actions
P A T I E N T
P E R S P E C T I V E
Expand debilitating conditions as recommended by Medicinal Marijuana Review Panel
Development of patient, caregiver, and physician mobile access portal
Reduce registration fees
March 27, 2018
March 27, 2019
March 27, 2018
Final Agency Decision adding new conditions was issued.
The Department will work to develop and/or procure an updated HIPAA-compliant comprehensive program portal with the ability to securely upload documents and submit payments. In an interim measure, Department IT staff have been able to provide mobile access to the current registry and payment processing system, which will go live in Spring 2018.
In advance of rulemaking process, the Department will begin charging reduced registration fees to qualifying patients to alleviate the financial burden on patients.
Propose to revise N.J.A.C. 8:64-1.2 to include these additional debilitating conditions.
page23image19304
Propose to revise N.J.A.C. 8:64-2.1(1)(c) to expand the reduced card fee to senior citizens and military veterans, and continue the reduced fee for those receiving public assistance. Additionally, the Department will reduce the registration fee for all qualifying patients and caregivers to $100 for the issuance or renewal of a registry identification card, which is valid for a two-year period.
page23image23000
Propose to revise N.J.A.C. 8:64-5.2 and -5.3, which created a petition process and review panel to make recommendations for the approval of additional debilitating medical conditions.
page23image24920
Streamline process for addition of debilitating conditions
Allow two caregivers per patient
Eliminate 10% THC limit
Allow patients to register at more than one ATC
Permit unlimited supply of product for patients receiving hospice care
Increase maximum monthly product limit
March 27, 2019
March 27, 2018
March 27, 2019
Legislative Timeline
Legislative Timeline
Legislative Timeline
In advance of formal rulemaking process, the Department will lift one-person limit on primary caregiver designation and allow two primary caregivers upon request.
Propose to revise N.J.A.C. 8:64-1.2 and associated rules to allow designation of a second primary caregiver who will be subject to the same requirements as the primary caregiver.
page23image36072
Propose to repeal N.J.A.C. 8:64-10.7(c) to remove the 10% THC limit for product sold.
page23image37304
Rulemaking consistent with statutory amendments.
Rulemaking consistent with statutory amendments.
Rulemaking consistent with statutory amendments.
Recommend amending N.J.S.A. 24:6I-7(a) to expand availability of edible products to all qualifying patients, regardless of age.
page23image40584
Allow edibles for all patients
Legislative Timeline
Rulemaking consistent with statutory amendments.
Recommend amending N.J.S.A. 24:6I-10(d) to expand patient access by allowing patients to be obtain product from any ATC.
page23image43784
Recommend amending N.J.S.A. 24:6I-10(a) to permit unlimited supply pf product to those receiving hospice care.
page23image45160
Recommend amending N.J.S.A. 24:6I-10(a) to increase monthly product limit to 4 ounces and an associated revision to N.J.S.A. 24:6I-6 to ensure that MMP patients have adequate legal protection against criminal charges for possession.
page23image47464 page23image47624
page23image48104 page23image48264 page23image48424 page23image48584 page23image48904 page23image49064 page23image49224 page23image49384 page23image49544 page23image49704 page23image49864 page23image50024 page23image50184
Attachment A: Executive Summary Matrix
page24image2008 page24image2168 page24image2328 page24image2488
A T C
P
E
R
S
P
E
C
T
I P
V A
E T
Item Description
Permit satellite ATC locations
Estimated Timeframe for Implementation *
March 27, 2018
Operational Actions
In advance of rulemaking process, the Department will consider waivers of N.J.A.C. 8:64-7.9 on a case-by-case basis.
Regulatory Actions
Propose to revise N.J.A.C. 8:64-7.9 to permit current ATCs to dispense at satellite locations and permit more than one cultivation site per ATC, with Department approval.
Statutory Actions
page24image14888 page24image15048
I
P E
H N
Y T S
I
P C
E I
R A
NS
P
P E
E C
R T
S I P V E
E C
T I V E
Create separate endorsements for ATC permits
Removal of non-profit requirement for original ATCs
Eliminate the physician registry
Eliminate psychiatrist evaluation for minors
March 27, 2019
Legislative Timeline
March 27, 2019
Propose to revise N.J.A.C. 8:64-7.1 and associated rules to create an endorsement system within the ATC permitting process. These endorsements would be broken down into the following activities: 1) cultivation and harvesting; 2) manufacturing and processing (including edible products); and 3) dispensing of usable marijuana.
page24image29288
The Department anticipates that this separate endorsement system will be utilized in a future Request for Applications to solicit applicants for ATC permits.
Rulemaking consistent with statutory amendments.
Propose to amend N.J.A.C. 8:64-2.4, which requires physicians interested in providing care to MMP patients to register with the Department. This amendment will allow any New Jersey physician in good standing with an active CDS registration issued by the State Division of Consumer Affairs to authorize medicinal marijuana for their patients meeting the program requirements.
Recommend the revision of N.J.S.A. 24:6I-7(a) to remove non-profit requirement for original ATCs.
page24image35960
In advance of the formal rulemaking process, the Department will begin the transition in Spring 2018 to eliminate the current physician registry procedure. This will allow program and IT staff to begin the review and potential reengineering of business processes to streamline the experience for patients, physicians, and program once the new portal is up and running. The portal would be rolled out in a series of modules next year. The Department will also create an optional public physician list for patient convenience.
page24image40944
March 27, 2019
Propose to revise N.J.A.C. 8:64-2.5 to remove the requirement for “written confirmation from a physician trained in the care of pediatric patients and from a psychiatrist” for a physician to authorize the use of medicinal marijuana for a minor.
page24image44016
Recommend amending N.J.S.A. 24:6I-3 to remove stipulation that certain conditions be “resistant to conventional medical therapy” to be considered a debilitating medical condition.
page24image45816
Allow use of cannabis as a first-line treatment
Legislative Timeline
Rulemaking consistent with statutory amendments.
page24image48544 page24image48704 page24image48864 page24image49024 page24image49344 page24image49504 page24image49664 page24image49984 page24image50144 page24image50304 page24image50464 page24image50624 page24image50784
* The estimated timeframe for implementation is given only for the operational and regulatory actions, which are within the direct control and purview of the Department and/or Board of Medical Examiners. Dates indicated in the cell represent the earlier estimated date of implementation or consideration where there is both operational and regulatory action items. Some operational actions may be
taken by the Department in advance of a formal rulemaking process, as these actions are consistent with Executive Order No. 6 and will not reduce protections or increase regulatory burdens.

page24image55280
EXECUTIVE ORDER NO. 6
WHEREAS, it is beyond dispute that patients suffering from debilitating medical conditions deserve to live in dignity with as little suffering as possible; and
WHEREAS, medical decisions must be based on science and health, not ideology or social policy; and
WHEREAS, scientific studies demonstrate that the medical use of marijuana has proven to be an effective treatment for patients suffering from painful, debilitating, and often chronic medical conditions; and
WHEREAS, New Jersey amended its state law to allow for the authorized medical use of marijuana with the passage of the New Jersey Compassionate Use Medical Marijuana Act in 2010; and
WHEREAS, 29 states have recently allowed the use of marijuana for medical purposes; and
WHEREAS, even a Republican-controlled Congress has repeatedly renewed the Rohrabacher-Farr Amendment, prohibiting the U.S. Department of Justice from using funds to interfere with state medical marijuana laws; and
WHEREAS, implementation of the New Jersey Compassionate Use Medical Marijuana Act was a lengthy process marked by significant delays, resulting in far fewer patients being served by the program than anticipated when the law was enacted; and
WHEREAS, there are currently five medical marijuana alternative treatment centers (ATCs) in operation in New Jersey; and
WHEREAS, only one additional ATC has been able to obtain a permit and is scheduled to begin operations in the foreseeable future; and
2
WHEREAS, of New Jersey’s nine million residents, only approximately 15,000 are able to participate in the State’s medical marijuana program; and
WHEREAS, in contrast, the medical marijuana program in Michigan, a state with a similar population to New Jersey, currently serves over 218,000 patients, and the program in Arizona, a state with a smaller population than New Jersey, serves over 136,000 patients; and
WHEREAS, the need for medical marijuana in New Jersey currently far exceeds the supply that the existing licensed ATCs in operation are able to provide; and
WHEREAS, giving patients a greater opportunity to obtain medical marijuana in accordance with State law will ensure that they are receiving a product tailored to their medical needs, and make them less likely to turn to potentially more harmful and less medically appropriate drugs such as opioids, the use of which was declared a public health crisis in Executive Order No. 219 (2017); and
WHEREAS, one study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health and the Philadelphia Veterans Affairs Medical Center found that the annual number of deaths from prescription drug overdose is 25 percent lower in states where medical marijuana is legal than in states where it is illegal; and
WHEREAS, my administration is committed to fulfilling the intent, promise, and potential of the New Jersey Compassionate Use Medical Marijuana Act by providing patients in New Jersey with a well-functioning and effectively administered medical marijuana program that best serves their medical needs;
3
NOW, THEREFORE, I, PHILIP D. MURPHY, Governor of the State of New Jersey, by virtue of the authority vested in me by the Constitution and by the Statutes of this State, do hereby ORDER and DIRECT:
1. The Department of Health (“Department”) and the Board of Medical Examiners (“Board”) shall undertake a review of all aspects of New Jersey’s medical marijuana program, with a focus on ways to expand access to marijuana for medical purposes. This review should include, but not be limited to:
a. An evaluation of the current rules regulating the operations and siting of dispensaries and cultivation facilities, particularly focusing on whether the rules should be revised to remove unwarranted obstructions to expansion;
b. A review of the current process for obtaining a license to operate a medical marijuana dispensary, including recommendations to expedite that process;
c. An examination of conditions for participating physicians in the program to ensure that any such requirements are not needlessly onerous;
d. An analysis of the current list of debilitating medical conditions for which medical marijuana may be authorized pursuant to N.J.S.A. 24:61-3, and a recommendation as to whether doctors should be given flexibility to make these determinations on their own;
e. An assessment of the methods through which patients or their primary caregivers are obtaining medical marijuana and a recommendation of whether rules should be amended to approve additional methods that could facilitate patient access;

3. [seal]
This Order shall take effect immediately.
Attest:
/s/ Matthew J. Platkin
Chief Counsel to the Governor
4
f. A review of regulations that govern the forms in which medical marijuana can be ingested, taking into consideration the needs for different methods for different patients; and
g. Any other aspect of the program within the Department or the Board’s discretion that hinders or fails to effectively achieve the statutory objective of ensuring safe access to medical marijuana for patients in need.
2. This review shall conclude within 60 days of this Order, at which time the Department and Board shall initiate the rulemaking process for appropriate regulatory reforms consistent with this Order.
GIVEN, under my hand and seal this 23rd day of January,
Two Thousand and Eighteen, and of the Independence of the United States, the Two Hundred and Forty-Second.
/s/ Philip D. Murphy
Governor   source http://www.nj.gov/health/medicalmarijuana/documents/EO6Report_Final.pdf